SYDNEY MEDICAL
SCHOOL
FOUNDATION
2011 ANNUAL REPORT
CONTENTS
02
02
04
06
2011 IN REVIEW
Highlights
President’s report
Dean’s message
08 OUR INITIATIVES
08 Scholarship recipients
10 Grant recipients
12
12
13
14
15
16
OUR DIVISIONS
Ageing and Alzheimer’s Research Foundation
Bone and Joint Research Foundation
Microsearch Foundation of Australia
Endocrinology and Diabetes Research Foundation
Sydney Burns Foundation
18
18
28
36
39
40
41
STATUTORY REPORTING
Governance Statement and Council members
Publications
Donations
Support Sydney Medical School Foundation
Income Statement
Balance Sheet
Sydney Medical School Foundation is
dedicated to improving the health of all
Australians by investing in a program of worldclass research and learning in Sydney Medical
School at the University of Sydney.
2
2011 HIGHLIGHTS
2.
1.
1. His Excellency, Mr Abel
Guterres, the Ambassador
of Timor-Leste (R)
presents pianist Alexey
Yemtsov (L) with a Tais
(traditional woven cloth)
as a gift of friendship
and thanks at NSW
Government House.
Highly awarded young pianist Alexey
Yemtsov played at NSW Government
House for supporters of the University
of Sydney Timor-Leste Health Fund.
The Fund aims to raise funds to support
training opportunities for East Timorese
medical and health professionals.
School Reception for friends and
supporters at NSW Government
House on 29 September 2011. Guests
enjoyed a presentation by Professor
Graeme Stewart who spoke about his
ground-breaking research into multiple
sclerosis.
$4.1 million was expended by Sydney
Medical School Foundation and its
Divisions to support research, education
and training at Sydney Medical School,
the University of Sydney in 2011.
Due to a $600,000 donation to the
Save Sight Institute, The Sydney
Medical School Foundation Billson
Research Laboratory was officially
opened by Her Excellency Professor
Marie Bashir AC CVO, Governor of New
South Wales on Friday 26 August 2011.
2. Professor Graham
Stewart presents to
guests attending the
Sydney Medical School
reception at NSW
Government House.
3. Sue Merrilees, newly
appointed Director of
Development, Sydney
Medical School.
Fellows of Sydney Medical School
Foundation and its Divisions published
160 articles and book chapters in 2011. $15.1 million in donation and bequest
income was recieved by Sydney
Sydney philanthropist Daniel Petre
Medical School Foundation and its
donated $2 million to establish the
Divisions in 2011.
Petre Chair of Prostate Cancer
Research, the first of its kind in
Australia.
Her Excellency Professor Marie Bashir
AC CVO, Governor of New South
Wales, hosted the Sydney Medical
Sue Merrilees was appointed the
new Director of Development, Sydney
Medical School. Sue joined the School
with more than 20 years experience in
fundraising and has held positions with
the University of Stanford, Columbia,
3.
and most recently, the University of
California, San Francisco.
4. The Hon. John Fahey
AC (Patron, Sydney Burns
Foundation) with The
Hon. John R Sharp at the
Sydney Burns Foundation
Cruise for a Cause.
5. Mr Edward Griffin (L)
with Dr Daniel Brown
(centre), Postdoctoral
Fellow in Meniere’s
Disease and Her
Excellency Professor
Marie Bashir AC CVO (R),
Governor of New South
Wales, at the Meniere’s
Research Fund Reception
at NSW Government
House.
4.
6. Professor Christopher
Semsarian at the
Sydney Medical School
Foundation Morning Tea.
5.
In the presence of Patron The Hon.
John Fahey AC, supporters of Sydney
Burns Foundation Cruise for a Cause
met on Sydney Harbour in October
2011. The event was made possible by
a number of generous individuals and
organisations (including The Elite Cruise
Company and the Foundation’s sponsor
Ausgrid) who donated their time, goods
and services which raised $25,000 for
burns medicine research. See page 16
for more information.
Total equity remained strong at $72.6
million.
Patron of the Meniere’s Research
Fund, and Governor of New South
Wales, Her Excellency Professor
Marie Bashir AC CVO, kindly hosted
a reception for the Fund and its
supporters at NSW Government House
on 13 October 2011.
6.
Friends and donors gathered to hear
Professor Christopher Semsarian,
Sydney Medical School Foundation
Fellow, present Getting to the Heart
of Sudden Death, at the Foundation’s
annual Morning Tea on 12 May
2011. The presentation focused on
Professor Semsarian’ s research on
heart disease in the young which was
honoured as among 10 of the Best
Research Projects 2010 by the National
Health and Medical Research Council
(NHMRC).
Joel Negin was awarded the 2011
Lucy F Falkiner Fellowship for his
project titled, Developing models of
non-communicable disease control in
developing countries by building on
systems built for the HIV response.
Administrative costs remained low at
3.5% of total income.
Yu Sung Hooi was awarded the 2011
Sydney Medical School Foundation
Scholarship for her project titled Posttranslational modifications of life-long
proteins in human lens.
26 recent fellows of Sydney Medical
School Foundation and its Divisions
were awarded NHMRC Project Grants
totalling $13.1 million over three years,
beginning in 2012.
The inaugural Medical Foundation
Professor in Adolescent Medicine,
Professor Kate Steinbeck, hosted
a reception on 27 February 2011 to
provide an update on her research
to date and her future goals for the
Chair of Adolescent Medicine. The
Chair champions research, teaching
and training, in the field of adolescent
medicine, and is funded in perpetuity
due to the generous donors and friends
of Sydney Medical School Foundation.
4
PRESIDENT’S REPORT
MR ROGER CORBETT, AO
In early 2009 I gladly accepted an invitation from Professor
Bruce Robinson, Dean of Sydney Medical School, to join the
Council of Sydney Medical School Foundation. That same
year I was honoured to become President of the Foundation;
a role which I knew would greatly contribute to the ongoing
success of Sydney Medical School through the support of its
research programs. On the 31 October 2011 with great regret
because of the pressure of other unavoidable commitments,
I resigned my position as President, and it is with great
pleasure that I introduce Mr Robert Salteri as the incoming
President of Sydney Medical School Foundation. Robert’s
acceptance of the position left me secure in the knowledge
that the role would be ably filled and that the commitment
to fundraising by the Foundation would be taken forward in
2012.
a world-class program of research and learning in Sydney
Medical School at the University of Sydney.
As a result, in 2011, the Foundation reviewed its approach
to fundraising by introducing a number of fundraising and
administrative committees. These committees provided
oversight and direction to the Foundation and helped
identify which research programs we could use to assist
our fundraising efforts. This contributed to Sydney Medical
School Foundation consolidating its role as the central
fundraising arm of Sydney Medical School. Headed by our
new Director of Development, Sue Merrilees, the year ahead
will see the Foundation further refine its ongoing fundraising
strategy. I warmly welcome Sue to the position. I also thank
Geoff Deakin for his role as the inaugural Director in early
2011.
During my tenure as President, Professor Bruce Robinson,
Dean of Sydney Medical School, has been invaluable in
providing advice and direction to the Foundation. His vision
for the School as a whole and his approach to medical
research in general has been inspiring and I look forward to
my continued engagement with Sydney Medical School in
the future.
With $4.1 million having been awarded to researchers in
2011, our firm commitment to fundraising allows us to meet
our main objective as a Foundation, that is, to provide much
needed financial support to the many student, early career,
and established medical researchers which form Sydney
Medical School.
Roger Corbett, AO
It gives me great pleasure to announce the following new
members to Council; Mr Tim Dolan, Mr Ian Horton (as our
Division Representative), and Mr David Kirk each accepted a
position on Council in 2011. Thank you for your commitment
to this great organisation.
I would also like to thank our continuing Council members
for their unwavering commitment to the Foundation during
a time which has been marked by change and upheaval. A
special thanks goes to Deputy President Nancy Dolan whose
legal expertise and knowledge has been without equal. I also
thank our outgoing Council members; Mrs Bunny GardinerHill, Dr John Gregory-Roberts, Mr Richard Scheinberg, Mrs
Victoria Harper, and Ms Louise Sylvan, for their long-term
Over the past three years Sydney Medical School Foundation support of myself and the Foundation. Each of these people
has seen a number of changes which have allowed it to grow has served the Foundation over a great many years and are a
its resources and effectiveness as a fundraising organisation. testament to its growth and success.
Under the leadership of Vice-Chancellor and Principal, Dr
It is with equal regret and sadness that I acknowledge the
Michael Spence, the University of Sydney released a new
passing of our Treasurer Leigh Minehan. Not only was Leigh
Strategic Plan and reviewed the Rules for Foundations.
a great friend, his knowledge of the financial systems of the
This enabled the Foundation and our Divisions to tighten
University and the subsequent work he undertook to update
our governance responsibilities. In accompaniment, Sydney
the University’s systems is most appreciated. Leigh was
Medical School issued its Strategic Plan, which amongst
other things, highlighted the research strategy of the School, greatly admired by both the Council and the staff of Sydney
helping us to better understand their funding needs and how Medical School Foundation and his intelligence and warmth
will be sorely missed.
the Foundation could best satisfy these.
To our valued supporters, thank you. Without your assistance
the Foundation would certainly fail in our mission to increase
the health and wellbeing of all Australians by investing in
Mr Robert Salteri (b,
President, Sydney Medical
School Foundation
“It is with great
pleasure that I
introduce Mr Robert
Salteri as the incoming
President of Sydney
Medical School
MR ROGER
Foundation.”
CORBETT, AO
MR ROBERT SALTERI
Since joining the Council of Sydney Medical School
Foundation in 2010, it has been a privilege to serve under the
Presidency of Roger Corbett, and it is an honour for me to
succeed him as President.
I look forward with keen interest to building on Roger’s
impressive record of service to the Foundation, along with
the support of the Dean, Professor Bruce Robinson, fellow
Council members, Director of Development, Sue Merrilees,
and our supporters.
Currently I serve on the boards of Tenix Group Pty Ltd (an
engineering services and enforcement management group)
and Olbia Pty Ltd (a funds management company). From
July 2001 to February 2007, I was Chief Executive Officer
of one of the Tenix’s major business units, Tenix Defence
Pty Ltd. Prior Tenix Defence I worked for Gold Copper
Exploration Pty Ltd in the Torres Strait and the Atherton
Tableland from 1986 and 1988 as a Project Manager. I joined
Transfield Construction in 1988 as General Manager of the
Victorian Division, and in 1991, was appointed Deputy Chief
Executive of AMECON, a marine and heavy engineering
company servicing defence, oil and gas and resource
industries which later became Tenix Defence.
Roger has detailed the work of the Foundation during 2011
and the governance and administrative changes introduced
to further improve our effectiveness. They have proven
highly effective in helping the Foundation to focus on its key
responsibilities.
Sydney Medical School at the University of Sydney has
an enviable record in research which the Foundation is
committed to supporting. We of course face challenges in
providing the increasing level of funding required for this
vital work, but I am confident that with the support of all
involved, we will continue to succeed.
Thank you for making this possible.
Robert Salteri
6
DEAN’S MESSAGE
PROFESSOR BRUCE ROBINSON, DEAN,
SYDNEY MEDICAL SCHOOL
It is once again a pleasure for me to contribute to the
Annual Report for Sydney Medical School Foundation. The
contribution that all our foundations make to the work of
Sydney Medical School must never be underestimated;
without this support there would be many things we simply
could not do. The funding of individual researchers is
extraordinarily valuable and the encouragement that I receive
from the foundations through their endorsement of our work
is a reward in itself. The support of the Foundation is an
enormous stimulus to us to keep striving to attract the best
researchers and students and to provide the best possible
opportunities for them to thrive. The financial pressures
on all of us with significant management roles within the
University are strong; the support of foundations is even
more valuable in such environments.
With so much attention to money and finance in recent
months, it is important to remember that Sydney Medical
School’s primary purpose is to provide high quality education
programs, perform high quality research and provide
healthcare to the people of NSW. I feel completely confident
that across all of these areas, we are doing very well.
So what does our 2011 report card look like?
Our medical program attracted record number of applications
this year, our international student application numbers
were the highest ever, and that has enabled us to enrol
even better students into the medical program for 2012. Our
postgraduate course student numbers are also looking very
good for next year. Our international numbers are against the
trend in the rest of the University.
The achievements of our researchers has been nothing
short of brilliant, with this faculty accounting for 80 of
the University’s 99 NHMRC Project Grants in November,
and all five Program and Development Grants announced
in December. We won 34 of the 41 Fellowships awarded
to the University of Sydney and two Centres of Research
Excellence.
The future for research is looking positive, with the six new
Themes gaining traction in bringing together people in our
dispersed sites for exchange of ideas and development
of research projects. We have good relationships with our
affiliated independent research institutes who contribute
strongly to our research output and training.
In international activities, 2011 was another year of
achievements. We hosted over 100 Australian Leadership
Awardees from China, India, Vietnam, Cambodia, Nepal and
Timor L’Este, and have started to see some of the earlier
ALA winners coming back to commence Masters or PhD
degrees. ALA winners develop strong relationships with
the University of Sydney and Australia and will be great
advocates for us in their countries in the future. Many
faculty members have won significant grants from AusAID
for projects in our neighbouring countries, enabling more
students to benefit from international experiences.
While faculty members perform at a high level in both
teaching and research, they also continue to provide
outstanding clinical service to the people of NSW. I have
a strong sense that NSW Health and our partner private
hospitals appreciate the value of close ties with the
University of Sydney. We will strengthen these ties even
more in 2012.
It is a pleasure to thank members of the Foundation Council
for their leadership over the past year. Roger Corbett’s
contributions to the Foundation and to the Medical School
have been greater than many people will know; we are
honoured that he has been able to find the time to chair
the Council for the last two years. We have benefitted
enormously. It is a great pleasure to announce another
person of outstanding calibre as our new President, Mr
Robert Salteri. Welcome and thank you, Robert, for taking
on this important role.
I am delighted to welcome other new Council members; Mr
Tim Dolan (the University’s Director of Development), Mr
Ian Horton (as our Division Representative) and Mr David
Kirk. Some long-serving ardent supporters of the Foundation
are now leaving the Council. Their contribution have been
many and varied and I gratefully thank them all: Mrs Bunny
Gardiner-Hill, Dr John Gregory-Roberts, Mrs Victoria Harper
Mr Richard Scheinberg and Ms Louise Sylvan.
It is with much sadness that I record the passing of our
Treasurer, Mr Leigh Minehan, a few days before the end of
2011. Rarely do we meet such a quiet but astute contributor.
A great loss to many.
Finally I must thank our professional staff, now led by our
new Director, Ms Sue Merrilees, so ably assisted by Ms
Melanie Balsom.
I am sure that all those within Sydney Medical School who
benefit from the work of the foundations will join me in
thanking all its members for what they have done and I look
forward to working with you again in 2013.
Professor Bruce Robinson
“The support of the Foundation
is an enormous stimulus to us
to keep striving to attract the
best researchers and students
and to provide the best
possible opportunities for them
to thrive.”
PROFESSOR BRUCE
ROBINSON
DEAN, SYDNEY MEDICAL
SCHOOL
8
SCHOLARSHIP RECIPIENTS
2.
1.
1. Siva Purushothuman,
recipient of the Bluesand
Foundation Scholarship
for Alzheimer’s disease
research.
THE MEDICAL FOUNDATION/BLUESAND FOUNDATION
SCHOLARSHIP FOR ALZHEIMER’S DISEASE
RESEARCH
Sivaraman Purushothuman successfully completed the
second year of his scholarship in 2011. While working
on his project titled, Impact of neuroprotectants on the
neuropathology of cerebral degeneration in Alzheimer’s
and Parkinson’s, Sivaraman presented at the Bosch Young
Investigators Symposium in December 2011 and has been
selected to present at the Australian Neuroscience Society
meeting in January 2012.
THE LUCY FALKINER FELLOWSHIP
Joel Negin
The Lucy Falkiner Fellowship provides $8,000 USD to a
medical graduate of the University of Sydney who wishes
to undertake postgraduate study or research in medicine at
Columbia Presbyterian Hospital in New York for up to three
months.
Joel Negin was awarded the 2011 fellowship for his project,
Developing models of non-communicable disease control in
developing countries by building on systems built for the HIV
response, and is scheduled to travel to the United States in
early 2012.
2. Emily Fuller, 2008
Sydney Medical School
Foundation Scholarship
Recipient.
Joel’s project will examine if and how the systems
developed to respond to HIV in sub-Saharan Africa can
be adapted to provide diagnostics, care and treatment
for non-communicable diseases such as hypertension,
diabetes and cardiovascular disease. Joel will work closely
with researchers at the Mailman School of Public Health,
Columbia University.
SUPPORT LEARNING AND RESEARCH
EXCELLENCE AT SYDNEY MEDICAL SCHOOL
“Helping medical students become the doctors and
researchers that the community needs is one of the
most important contributions we can make to the future
of medicine and healthcare. I invite you to support our
scholarship program.” Professor Bruce Robinson, Dean.
If you would like to support an existing scholarship at
Sydney Medical School, or arrange a meeting to discuss
creating a new scholarship, please contact:
Sydney Medical School Foundation
T +61 2 9351 7315
F +61 2 9036 9182
E [email protected]
sydney.edu.au/medicine/foundation
“This support has
been invaluable and so
greatly appreciated.”
JASON COOMBES
SYDNEY MEDICAL
SCHOOL FOUNDATION
SCHOLARSHIP
SYDNEY MEDICAL SCHOOL FOUNDATION
SCHOLARSHIP
2007 Recipient: Jason Coombes
After being granted a six month extension for his project,
Actin microfilament cytoskeleton and its role in maintaining
cellular structure and function, 2007 Scholarship recipient
Jason Coombes submitted his PhD thesis for examination.
Upon successfully completing his scholarship Jason said,
“I’d like to again personally thank Sydney Medical School
Foundation for their scholarship support during my PhD
studies. This support has been invaluable and so greatly
appreciated.”
2008 Recipient: Emily Fuller
Our 2008 recipient Emily Fuller also completed her
scholarship in 2011. While working on her project titled
Investigating the Mechanisms of Knee Meniscus
Degeneration, Emily was invited to attend the Osteoarthritis
Research Society International (OARSI) annual conference
held in Brussels, Belgium from the 23-26th of September.
Her submitted abstract, Metalloproteinase Expression and
Activity in the Meniscus: Implications for the Pathogenesis
of OA, was chosen for oral presentation in a session
alongside other well-known researchers in this field.
2010 Recipient: Elizabeth Dunford
Elizabeth Dunford entered the second year of her
Scholarship in 2011, continuing her project, Reducing the
burden of cardiovascular disease and associated risk factors
by changing the food supply.
Elizabeth’s research involved the establishment of a
comprehensive database of processed food products in order
to track their saturated fat, sugar and salt levels. She hopes
that the database (which contains some 10,000 entries
and is updated annually) will offer a unique opportunity to
advocate for and track the reformulation of processed foods,
with the hope that even small improvements in nutrient
composition will have significant population health benefits.
2011 Recipient: Yu Sung Hooi
Our most recent recipient, Yu Sung Hooi, was awarded
the 2011 scholarship for her project, Post-translational
modifications of life-long proteins in human lens.
The project will investigate the characteristics of proteins in
human lenses among different age groups in order to better
understand their potential role in age-related diseases.
10
GRANT RECIPIENTS
Professor Jacob George,
Robert W Storr Professor
of Hepatic Medicine &
Sydney Medical School
Foundation Fellow
SYDNEY MEDICAL SCHOOL FOUNDATION
Professor Thomas Becker
Title: Chair of Developmental
Neurobiology, Sydney Medical School
Foundation Fellow
Unit: The Brain & Mind Research
Institute
Project: Zebrafish, a vertebrate model
organism for human genetic disease
Amount: $920,000 (2008-2011)
Dr Clara Chow
Title: Sydney Medical School
Foundation Chapman Fellow
Unit: The George Institute for Global
Health
Project: Development of a program
of research in the prevention of
cardiovascular disease
Amount: Approx. $450,000 (2010-2014)
Associate Professor Ruth Colagiuri
Title: Sydney Medical School
Foundation Fellow
Unit: Menzies Centre for Health Policy
Project: Preventing Cardiovascular
Disease and Diabetes in Pacific Island
Countries: An Environmental Approach
Amount: $535,000 (2010-2012)
Associate Professor Qihan Dong
Title: Sydney Medical School
Foundation Fellow
Unit: Central Clinical School
Project: Prostate cancer
Amount: $37,000 (2011)
Associate Professor Gemma Figtree
Title: Sydney Medical School
Foundation Chapman Fellow
Unit: Kolling Institute of Medical
Research
Project: Regulating the Molecular Pump
of the Heart and Developing Cardiac
magnetic Resonance
Amount: Approx. $700,000 (2009-2013)
Professor Jennifer Gamble
Title: Sydney Medical School
Foundation Fellow
Unit: Centenary Institute
Project: Understanding Blood Vessel
Formation and Function
Amount: $900,000 (2007-2011)
Professor Jacob George
Title: Robert W Storr Professor of
Hepatic Medicine, Sydney Medical
School Foundation Fellow
Unit: Storr Liver Unit
Project: Mechanisms of liver injury
and liver disease progression, including
research on hepatocellular cancer,
Robert W Storr Professor of Hepatic
Medicine (2006-current)
Amount: Chair funding plus $2,040,000
(2007-2012)
Professor Mark Gillies
Title: Sydney Medical School
Foundation Fellow
Unit: Sydney Eye Hospital
Project: The Macular Research Group
Amount: Approx. $325,000 (20092014)
Professor Ian Kerridge
Title: Sydney Medical School
Foundation Fellow
Unit: Centre for Values and Ethics and
the Law in Medicine
Project: Restoring value(s) to medicine:
An examination of the scientific and
ethical foundations of medicine
Amount: $ 403,000 (2008-2011)
Dr Eddie Kizana
Title: Sydney Medical School
Foundation Chapman Fellow
Unit: Westmead Clinical School
Project: Molecular Basis of Cardiac
Conduction
Amount: Approx. $366,000 (20092013)
Associate Professor Craig Munns
Title: Sydney Medical School
Foundation Fellow
Unit: The Children’s Hospital at
Westmead
Project: Osteogenesis Imperfecta (AKA
Brittle Bone Disease) Fellowship
Amount: $264,000 (2011-2012) Funded
by the Thyne Reid Foundation
Professor Kathryn North
Title: Douglas Burrows Professor of
Paediatrics & Child Health
Unit: The Children’s Hospital at
Westmead
Project: Douglas Burrows Chair
of Paediatrics & Child Health
(2004-current)
Amount: Chair funding
Professor Tania Sorrell
Title: Sydney Medical School
Foundation Fellow
Unit: Sydney Institute for Emerging
Infectious Diseases and Biosecurity
(SEIB)
Project: Sydney Institute for Emerging
Infectious Diseases and Biosecurity
(SEIB)
Amount: $926,000 (2009-2014)
Professor Kate Steinbeck
Title: Medical Foundation Chair in
Adolescent Medicine, Sydney Medical
School Foundation Fellow
Unit: The Children’s Hospital at
Westmead
Project: Medical Foundation Chair in
Adolescent Medicine (2010-current)
Amount: $715,000 (2010-2014)
Professor Gerard Sutton
Title: Sydney Medical School
Foundation Fellow
Unit: Save Sight Institute
Project: Sydney Medical School
Foundation Professor of Corneal &
Refractive Surgery
Amount: Approx. $670,000 (2010-2014)
DIVISIONS
AGEING AND ALZHEIMER’S
RESEARCH FOUNDATION
Dr Kerrin Bleicher
Frederick Russell Scholarship
Dr Nichola Boyle
Doreen Porter Scholarship
Professor David Le Couteur
Ageing and Alzheimer’s Research
Foundation Fellow
Professor Robert Cumming
Ageing and Alzheimer’s Research
Foundation Fellow
Dr Danijela Gnjidic
Ageing and Alzheimer’s Research
Foundation Fellow
Professor Andrew McLachlan
Ageing and Alzheimer’s Research
Foundation Fellow
Ms Shajjia Razi
Gabrielle Lee Scholarship
Mrs Jean Reid
Margaret Brown Wright Scholarship
Dr Fiona Stanaway
Ageing and Alzheimer’s Research
Foundation Fellow
Dr Dmitri Svistounov
Ageing and Alzheimer’s Research
Foundation Fellow
BONE AND JOINT RESEARCH
FOUNDATION
Institute of Bone and Joint Research
Support Grant
Dr Benjamin Chan
Bone and Joint Research Foundation
Postdoctoral Fellow
Dr Elizabeth Clarke
Lincoln Director of the Murray Maxwell
Biomechanics Laboratories
ENDOCRINOLOGY AND DIABETES
RESEARCH FOUNDATION
Dr Xiaoyu Wang
EDRF Postdoctoral Fellow
$100,000
Dr Jencia Wong
Research support for funds for clinical
diabetes and biobanking studies
$40,000
MICROSEARCH FOUNDATION OF
AUSTRALIA
Dr Eithne Cunningham
Earl Owen Fellow
$90,000
Dr Miriam Habib
Myee Codrington Scholarship
$35,000 stipend plus $20,000
consumables
Dr Thomas Pennington
Microsearch Foundation of Australia
Scholarship
$5,000
Dr Chuanmin Wang
Microsearch Foundation of Australia
Fellow
$45,000
12
OUR DIVISIONS
AGEING AND ALZHEIMER’S
RESEARCH FOUNDATION
In 2011, the Ageing and
Alzheimer’s Research
Foundation continued to
support research programs
at the Centre for Education
and Research on Ageing
(CERA).
CERA is a multidisciplinary
Research Centre that
aims to expand and share
knowledge of human ageing,
so that the health and
quality of life of older people
can be improved.
Dr Danijela Gnjidic, 2011
Postdoctoral Fellow.
In 2011, this support included two PhD scholarships awarded
to Kerrin Bleicher and Jean Reid for their epidemiological
studies forming part of the Concord Health and Ageing
in Men Project (CHAMP). Kerrin’s research focused on
muscle function and falls in older men while Jean studied the
relationship between nutrition and the rate of ageing.
frailty are predicted by polypharmacy and medications with a
strong sedative and anticholinergic action. Danijela was also
a lead author of a paper published in the Christmas edition
of the British Medical Journal which showed the relationship
between gait speed and mortality.
Danijela played a key role in developing, and is the Chief
Investigator on, a collaborative NHMRC grant entitled High
risk prescribing in older Australians: prevalence, outcomes
and potential for intervention led by Professor Emily Banks.
The grant secured $577,000 over a three year period
which will commence in 2012. Danijela was also successful
in her application for a prestigious NHMRC postdoctoral
fellowship which will span four years. This fellowship, under
the supervision of Professor Andrew McLachlan will allow
The Foundation also supported a postdoctoral fellowship
her to continue her studies that aim to improve the use of
held by Dr Danijela Gnjidic who completed her PhD in
medications in older people, particularly frail older people
2010. Her thesis, entitled, Impact of Drug Burden Index on
outcomes and prescribing in older adults, generated ten peer where the current evidence base for the use of medications
reviewed research publications. During her fellowship Danijela is very limited. Danijela has been an extremely productive
scientist during her PhD and early postdoctoral appointments
undertook many studies in CHAMP while contributing
and has been well rewarded by her NHMRC fellowship and
to several national and international collaborations on
project grant. Her research on medications can be translated
medication use by older people. This research focussed on
directly into clinical practice and has the potential to improve
adverse outcomes of medications in older people including
the lives and wellbeing of frail older people the world over.
impaired cognition function, mobility, and activities of daily
living. One of these studies showed that the highest levels of
CHAMP is a large prospective multidisciplinary study of
1705 older males living in the Concord area investigating
the biology of ageing with a particular focus on hormones,
and the development of age-related diseases and geriatric
syndromes. The CHAMP study is based at the Centre for
Education and Research on Ageing and the ANZAC Research
Institute at Concord Clinical School.
BONE AND JOINT RESEARCH
FOUNDATION
In 2011 the Bone and Joint
Research Foundation
(BJRF) enabled a number of
important research projects,
and funded several research
personnel, based at the
Institute for Bone and Joint
Research (IBJR).
Once such project was
a public seminar held in
October at the Kolling
Institute, Royal North Shore
Hospital (RNSH).
(L - R) Professor David Sonnabend, Professor Lyn
March and Professor Bruce Robinson present Professor
Philip Sambrook with a lifetime achievement award in
recognition for his dedication to bone and joint research.
The seminar presented the highlights of bone and joint
research conducted at Sydney Medical School’s Northern
Clinical Campus, and honoured the lifetime contribution
of Professor Philip Sambrook, the Florence Cope Chair of
Rheumatology at RNSH, to musculoskeletal research. The
salary for the Florence Cope Chair is provided in part by the
BJRF through a generous bequest from the Estate of the
Late Margaret Liggins. Professor Sambrook has been active
in and an advocate for bone and joint research for over
25 years. His particular areas of interest, on which he has
published over 270 peer-reviewed articles, are osteoarthritis
and osteoporosis. The public seminar was attended by over
120 people, including rheumatologists from across NSW.
was demonstrated by its review as a “Research Highlights
Editorial” in Nature Reviews in Rheumatology (2011;7:438).
Dr Elizabeth Clarke is the Lincoln Director of the Murray
Maxwell Biomechanics Laboratories, a position funded in
part by the BJRF through the Dorothy Caton bequest.
Liz’s research interests are in age-related changes in tissue
and joint biomechanics and how these affect disease
mechanisms, injury thresholds, and recovery. In collaboration
with colleagues at UNSW and INSERM (France) Liz was
awarded an ARC grant at the end of 2011 to study nonlinear
viscoelastic properties of paediatric soft tissues throughout
development. This project uses a novel non-invasive MRI
method to determine how the soft tissues of the human
Dr Benjamin Chan is a postdoctoral scientist at the Raymond body change during normal development, and how these
Purves Bone and Joint Research Laboratories in the Kolling
changes affect their response to mechanical forces. This
Institute. Ben is studying the role of a specific protein
data will be useful for understanding childhood injury
(sclerostin) in cartilage and bone pathology in osteoarthritis. mechanisms, and how diseases affect soft tissues in children.
This work is defining a new mechanism of disease, and
Liz was also awarded a CASS Foundation travel grant in 2011.
may provide a novel therapeutic target for arthritis. Ben’s
The award enabled her to present new research on spinal
work was initially funded by the Alec Brennan Fellowship
cord injury at the International Society for Biomechanics
through the BJRF, and in November 2011 received Project
Conference in Belgium, and funded a two week laboratory
Grant funding for three years from the NHMRC. The
visit to the International Collaboration on (Spinal Cord)
initial results from Ben’s studies were published in 2011 in
Repair Discoveries in Canada, to learn new techniques in
Osteoarthritis and Cartilage, and the importance of the work spinal injury research and dynamic joint MRI scanning.
14
OUR DIVISIONS
MICROSEARCH FOUNDATION
OF AUSTRALIA
2.
1. Dr Miriam Habib, Myee
Codrington Scholarship
Recipient.
2. Dr Eithne Cunningham,
Earl Owen Fellow.
1.
The Microsearch Foundation of Australia supports research
and teaching of microsurgery - the joining together of
very small blood vessels and nerves using an operating
microscope and very fine needles and sutures. In 2011
Microsearch supported research programmes focused
on improving microsurgical outcomes in two main areas:
increasing the ability of replanted, transplanted, and
reconstructed tissues to withstand damage when their blood
supply is interrupted, and later restored, and investigating
novel treatments by which organ transplants could be
accepted without the need for powerful immunosuppressive
drugs.
Support included the Myee Codrington scholarship, currently
held by Dr Miriam Habib, which consists of a stipend of
$35,000 plus $20,000 for research consumables. Dr Habib’s
project involves examining the use of molecules such as
esRAGE and HMGB1 to prevent the damage that occurs
when the blood supply to a tissue is interrupted and then
restored. Microsearch also funded the Earl Owen fellowship
which totalled $90,000, to Dr Eithne Cunningham, who
is investigating gene therapy approaches to preventing
rejection of organ transplants. Dr Chuanmin Wang received
salary support of $45,000 for his role in microsurgical
experiments and for teaching microsurgery students. While
Dr Thomas Pennington received a $5,000 scholarship for
research support to develop new models of free flap surgery.
2011 saw the involvement of active clinical microsurgeons
in the Microsearch Council to provide ongoing direction of
clinically relevant research and teaching of microsurgery. Dr
Alfred Lewis and Dr Paul Curtin were appointed to Council
with the aim to encourage the involvement of the wider
plastic surgery and microsurgery community of NSW. It
is envisaged that they will contribute to the Microsearch
Foundation by:
1.
Shaping the direction of future research projects with
active involvement in the Scientific Advisory Committee
2.
Promoting Microsearch as an important vehicle for
multidisciplinary microsurgery research in NSW
3.
Identifying funding opportunities to provide additional
laboratory based scholarships for training microsurgeons
4.
Identifying and selecting microsurgery trainees for
scholarship support
Microsearch took part in both Sydney Development Fund
appeals run by the University of Sydney in 2011. Microsearch
was also successful in obtaining a grant from Perpetual
Trustees. Income from fundraising and bequests in 2011
totalled $219,000.
ENDOCRINOLOGY AND DIABETES
RESEARCH FOUNDATION
The Endocrinology and Diabetes Research
Foundation (EDRF) aims to raise funds
to support research conducted by the
Department of Endocrinology at the
University of Sydney and Royal Prince
Alfred Hospital (RPAH). In 2011, our
main research focus continued towards
improving our understanding of the cause
and treatment of diabetic complications.
Research programs supported by the EDRF
included the pathogenesis of diabetes
complications and methods to limit its
development and potentially reverse the
disease.
Successful PhD student,
Dr Lisa Lo
In 2011 work supported by the EDRF was published in the
Journal of Hepatology which highlighted a novel model
of diabetes added to high fat feeding which leads to liver
fibrosis termed NASH. Congratulations go to Ms Lisa Lo
for the award of her PhD on this work. Another recent
publication in the Journal of Cell Communication and
Signalling addressing diabetic kidney disease investigated
how advanced glycation present in diabetes induces growth
factors and tissue changes in the kidney and its cells. This
data helped to clarify how diabetes through growth factors
causes kidney injury and failure.
blood glucose meters when certain types of dialysis is
occurring in kidney failure.
From the translational research perspective PhD student,
Ms Frances Henshaw, treated human diabetic foot wounds
with the bee hive derived product, Propolis – a potent
anti-inflammatory and anti-bacterial that has been used
for thousands of years to treat cuts and abrasions but has
not previously been systematically studied in diabetes. In
2008, we published that Propolis improves wound healing
in a rodent model of diabetes and Frances’ clinical data also
suggests that the agent holds promise in foot ulcer healing in
human diabetes.
Thank you to all staff for having worked enthusiastically in
2011 and sincere congratulations to Associate Professor
Marg McGill for her 2011 Australia Day Honours AM award
for services to and leadership in diabetes, including diabetes
education at an international level. RPAH Diabetes Centre
has been successful in becoming an IDF Centre of Education
Excellence, which was announced in December 2011 in
Dubai at the IDF World Congress. Congratulations again to
Professor McGill in her efforts to achieve this outcome.
Studies of blood glucose meters by Dr Nimalie Pereira have
shown the suboptimal performance of blood glucose meters
in an antenatal diabetes clinic, and dangers in using certain
Dr Jencia Wong continued important data base analysis
and found that common clinical parameters may be used
to identify patients who will need insulin treatment in
gestational diabetes mellitus; in type 2 diabetes, angiotensinconverting enzyme inhibition and angiotensin II receptor
blockade in combination for blood pressure control may have
an important role to play in some people with diabetes but
not in others. She is now working on sample biobanking and
researching cases of atypical diabetes.
The EDRF has received generous donations from several
individuals and organisations and we thank all donors for
their generosity. Professor Stephen Twigg, EDRF Director.
16
OUR DIVISIONS
SYDNEY BURNS FOUNDATION
Sydney Burns
Foundation Council
members at Cruise
for a Cause: (L to R)
Mr Kevin Cranfield
(Treasurer), Mr
Chris Hope (Council
member), Professor
Peter Maitz (Deputy
Chair), Professor Peter
Haertsch (Chair), Ms
Gillian Guthrie
(Council member), with
The Hon. John Fahey
AC (Patron).
The start of Sydney Burns Foundation’s third year in
existence saw a concerted fundraising drive by the Council
and a committee formed for that purpose.
The result was a substantial increase in income from
donations to the Foundation – almost $100,000 more than
contributions received in the previous year.
Apart from pursuing corporate donations, the Fundraising
Committee concentrated its efforts on organising a harbour
cruise and cocktail party, predicated on the generous
donation for the night of the Blue Room, an 85ft glass dining
vessel, by the Elite Cruise Company.
Hosted by Sydney Burns Foundation patron, The Hon. John
Fahey AC, the Cruise for a Cause raised $24,345 from a
combination of ticket sales, donations, a silent auction of
donated items and a very lively live auction conducted by
auctioneer, Louise Purtle, who kindly donated her powers of
persuasion to the cause.
In corporate donations, Sydney Burns Foundation was
grateful to receive a contribution of $50,000 from Ausgrid,
with a commitment for an additional sponsorship of $50,000
in 2012.
The Foundation continued to seek sponsorship and
workplace giving agreements from other corporations in
those divisions of industry where burn injuries can be a
hazard of the job.
The Foundation’s most pressing aim at present is to help
fund the painstaking development of a laboratory-cultured,
full-thickness, replacement skin. At present full-thickness
skin grafts must be taken from the undamaged skin of burn
victims, which itself leaves a painful scar. In severe cases,
burn patients do not have enough healthy skin for fullthickness grafting.
The research is being conducted by leading researchers
under the supervision of Burn Injury and Reconstructive
Surgery Professor Peter Maitz at Concord Hospital’s Skin
Laboratory and the Anzac Institute. They are already welladvanced in their development of this potentially life-saving
and life-improving replacement skin.
OUR SPONSOR
SYDNEY BURNS FOUNDATION
CRUISE FOR A CAUSE
THANK YOU!
The Council of the Sydney Burns
Foundation would like to thank our
Sponsor Ausgrid, and the following
supporters of Cruise for a Cause, who
contributed to us raising $25,000 for
research into burns medicine:
•
•
•
•
•
•
•
•
•
•
•
•
•
Raphael Jewellers
Porsche Sydney South
Campus Travel
OHKI
The Hotel Cairns
BridgeClimb Sydney
Henry Bucks
James & Dean Floral Design
Rugby Union Players Association
Bentleys
Paragem
Stewart Partners
Coca Cola
The Elite Cruise Company
A special thank you to Don Sharp
at the Elite Cruise Company for his
generous support of this function.
For more information on the Elite
Cruise Company please visit their
website at:
www.elitecruise.com.au
OUR SUPPORTERS
18
GOVERNANCE STATEMENT AND
COUNCIL MEMBERS
Sydney Medical School Foundation
recognises the importance and benefit
of reviewing its adoption and alignment
with governance principles and provides
the following report:
PRINCIPLE 1 – LAY SOLID
FOUNDATIONS FOR MANAGEMENT
AND OVERSIGHT
NATURE OF THE ENTITY
Sydney Medical School Foundation
is a part of the University of Sydney
ABN 15211513464 and not separately
incorporated under a State or
Commonwealth Act. The Foundation
is required to gain prior approval for its
fundraising activities from the Director
of Development up to $100K, the
Provost and DVC from $100k to $1m
and the Vice Chancellor over $1m. The
Foundation’s activities are not-for-profit
and covered by the DGR status of the
University of Sydney. The University
is exempted from the requirement to
hold an Authority to Fundraise and
obligations upon holders of such an
authority but is still required to comply
with the balance of provisions of the
Charitable Fundraising Act
ROLES OF COUNCIL AND
MANAGEMENT
The Foundation operates under
the authority of the Senate of the
University of Sydney, as approved
on 1 July 2006 and has no powers of
delegation. The Foundation conducts
its affairs pursuant to the Foundation
Rules and the relevant policies of
the University. The Foundation had
its annual fundraising plan approved
and was able to meet its objectives.
The Foundation is to be reviewed
every three years from the date of its
approval. No review was undertaken
during 2011.
PRINCIPLE 2 – STRUCTURE OF THE
COUNCIL TO ADD VALUE
STRUCTURE OF THE COUNCIL
OF SYDNEY MEDICAL SCHOOL
FOUNDATION
The Council of the Foundation in 2011
consisted of the following members:
Mr R Corbett AO
Qualifications and experience: Roger
Corbett has been involved in the retail
industry for over 40 years. He started
off loading trucks at the Grace Bros
Chatswood store in the early 1960s and
rose over some 25 years to become a
member of the Board of Grace Bros
holding the position of Merchandise
Director and later as Stores Director.
In late 1984 Roger joined the Board of
David Jones Australia as Director of
Operations. In 1990 he was appointed
to the Board of Woolworths Limited and
to the position of Managing Director
of BIG W Australia. Over the next 10
years Roger subsequently, in addition
to his new role as Deputy Group
Managing Director, held the positions
of Managing Director – Retail, Chief
Operating Officer and CEO-elect. On
1 January 1999, Roger was appointed
Chief Executive Officer of Woolworths
Limited. Roger Corbett retired as CEO
and a Director of Woolworths Limited
on 30 September 2006. In June 2003,
Roger was awarded a Member in the
Order of Australia (AM) in the Queen’s
Birthday Honours List for “service
to the retail industry, particularly as
a contributor to the development of
industry policy and standards, and to
the community.” In June 2008, he was
elevated to an Officer in the Order of
Australia (AO) for “service to business,
particularly through leadership and
executive roles in the retail sector and a
range of allied organisations, and to the
community.” Roger’s current Executive
and Board responsibilities include,
Member of the Board of Directors,
The Reserve Bank of Australia; Board
of Directors, Wal-Mart Stores, Inc.
USA; Chairman, Fairfax Media Limited;
Chairman, PrimeAg Limited; Chairman,
Mayne Pharma Group Limited;
Chairman of the Salvation Army
Advisory Committee; Member of the
Dean’s Advisory Group, Sydney Medical
School, the University of Sydney;
Member of the Advisory Committee
of the Australian Graduate School of
Management, University of New South
Wales; Chairman of the Advisory Board
and the Sydney Children’s Hospital
Network (Randwick & Westmead).
Current Term of Appointment:
30/03/2009 to 31/10/2011
Special responsibilities: President (until
31/10/2011)
Number of meetings attended: 5,
eligible to attend: 5
Mr R Salteri
Qualifications and experience:
Robert Salteri is a Director of the
major Australian industry/technology
company, the Tenix Group, with
headquarters in Sydney, Australia. He
is also a director of a medium sized
funds management company. From
July 2001 to February 2007, he was
Chief Executive Officer of one of the
Group’s major business units, Tenix
Defence Pty Ltd, prior to its sale in
2007. Robert worked for Gold Copper
Exploration Pty Ltd in the Torres Strait
and the Atherton Tableland from 1986
and 1988 as a Project Engineer and
then as Project Manager. He joined
Transfield Construction in 1988 as
General Manager of the Victorian
Division, and in 1991, was appointed
Deputy Chief Executive of AMECON, a
marine and heavy engineering company
servicing defence, oil and gas and
resource industries. In 1993, AMECON
become Transfield Shipbuilding Ltd. In
1994, Robert was appointed Director,
Victoria, for Transfield Holdings Pty
Ltd, and later Deputy Chief Executive,
Transfield Construction. Following the
reorganisation of the former Transfield
Group in 1997, Robert became an
Executive Director of Tenix Pty Limited.
Robert has been a director of Boutique
Wines Australia and Australian Theatre
for Young People. He was born in
1961, married Kelly in 1987, and they
have three children and live in Sydney.
Robert’s interests include skiing and
sailing. He represented Australia at the
World 12 Metre Sailing Championships
in Sardinia in 1984.
Current Term of Appointment:
22/03/2010 to AGM 2013
Special responsibilities: President (from
AGM 2011)
Number of meetings attended: 4,
eligible to attend: 4
Group in the OECD.
Current Term of Appointment:
20/04/2004 to 29/08/2011
Special responsibilities: Deputy
President (until AGM 2011)
Number of meetings attended: 2,
eligible to attend: 4
professional experience largely in Audit
and in the Business Advisory area. His
major clients over the years included;
Medical Benefits Fund of Australia; QBE
Insurance Group; Royal & Sun Alliance
Insurance Group (now part of Suncorp);
Rheem Australia Limited (when a
public company); AGC Insurances.
Ms N E Dolan
Following his retirement from the
Qualifications and experience: Nancy
Australian firm of PwC he undertook
Dolan BA LL B (Hons) is an Honorary
global leadership roles as Global Leader
Fellow of Sydney Medical School
– Network Transformation; leading a
at the University of Sydney. After
major change management program
beginning practice in New Zealand,
aimed at achieving greater alignment of
Nancy became a solicitor and partner
PwC firms and to enhance their global
in the commercial disputes group
clients’ service experience and as a
of Mallesons Stephen Jacques in
leader of the Global Network Review
Sydney, focusing on contracts, equity,
Programme. Leigh was also Chairman
Ms L Sylvan
administrative law, professional
of Munich Reinsurance in Australasia.
Qualifications and experience:
negligence law and commercial
Outside of work Leigh was a keen
Louise Sylvan is a Commissioner
disputes. She subsequently became
yachtsman, having competed in nine
of the Productivity Commission.
General Counsel and a partner of
Sydney-Hobart Yacht Races (winning
She was formerly Deputy Chair
Coopers and Lybrand and its successor twice) and represented Australia on a
of the Australian Competition and
firm PricewaterhouseCoopers, providing number of occasions. He was previously
Consumer Commission, the Chief
legal advice to executive leaders about
involved in yachting administration as
Executive (and formerly Head of
partnership arrangements, the firm’s
a director of Yachting Australia (peak
Policy) of the Australian Consumers’
operations, risk management and the
body for the sport) and Commodore
Association (ACA/CHOICE), and the
management of claims. Nancy was a
of The Cruising Yacht Club of Australia
Founding Director of the Consumers’
consultant from 2000 to 2003. From
(responsible for the Sydney – Hobart
Health Forum of Australia. She was
2004 to 2007 Nancy was General
Yacht Race). Leigh was also a former
also elected to serve on the peak
Counsel of the University of Sydney,
President of a leukaemia and cancer
international body of the global
responsible for co-ordinating the
research foundation, Cure Cancer
consumer movement initially as an
provision of legal services to the
Australia. In 2000 he was appointed to
Executive Member and subsequently
University, for providing advice to the
the Board of Queenwood School for
Treasurer, Vice-President and President Senate, Chancellor, Vice-Chancellor and Girls and in 2007 appointed Chairman.
of Consumers International. Current
senior executives and for establishing
Leigh with his wife Jo, had two children,
community and government Boards
and leading an Office of General
Phoebe and Sam.
include: President, Bush Heritage
Counsel.
Current Term of Appointment:
Australia; Board Member, Diplomacy
Current Term of Appointment:
30/03/2009 to 28/12/2011
Training Program UNSW; Council
21/04/2008 to AGM 2012
Special responsibilities: Treasurer
Member, Australian Bureau of Statistics Special responsibilities: Deputy
Number of meetings attended: 2,
Advisory Council. Louise was one of
President (from AGM 2011)
eligible to attend: 5
20 people selected as Australia’s True
Number of meetings attended: 5,
Dr J Gregory-Roberts
Leaders in 2002 by the Australian
eligible to attend: 5
Qualifications and experience: John
Financial Review BOSS magazine. She
Gregory-Roberts was President of
has also served on the Prime Minister’s Mr L P Minehan FCA
Qualifications and experience:
Sydney Medical School Foundation
Economic Planning Advisory Council
Leigh
Minehan
was
with
from 2004 to 2005. He has been an
(EPAC) for six years, chaired the
Honorary Governor of the Foundation
Australasian Consumer Fraud Taskforce, PricewaterhouseCoopers (PwC) for
over 40 years and was a partner for
since 1994 and a member of the
was a member of the Commonwealth
28 years. For the period 2000 to 2008
Executive Committee from 2000 to
Government’s Expert Group on
2005. He is an ophthalmologist in
E-Commerce, a charter member of the Leigh was a member of the Australian
Firm’s Management Executive and
private practice and a Visiting Medical
international group which created the
Officer and Chairman of the VitreoAdelphi Charter on Intellectual Property, Firm wide Leadership Team and held
the position of Deputy Chief Executive
retinal Unit at the Sydney Eye Hospital.
served on the Board of the Public
Officer
for
PwC
in
Australia.
Prior
Dr Gregory-Roberts is a Life Governor
Interest Advocacy Centre, and chaired
to that time he had a wide range of
of the Royal Institute for Deaf and Blind
the Consumer Economics Working
20
GOVERNANCE STATEMENT
AND COUNCIL MEMBERS
Children at North Rocks, having been
the Honorary Ophthalmologist since
1978. He joined the Board in 1991 and
became Vice-President in 2003. He is a
member of the Board of Management
of the Sydney Eye Hospital Foundation.
From 1999 to 2005, Dr GregoryRoberts was a Board Member and
member of the Executive of the Sydney
International Piano Competition. As
a former Trustee of Centennial Park,
he was Chairman of the Bicentennial
Committee from 1985 to 1988.
Current Term of Appointment:
27/04/1993 to AGM 2011
Special responsibilities: Governor
Number of meetings attended: 0,
eligible to attend: 2
Professor D Burke AO
Qualifications and experience: David
Burke is a neurologist who was
awarded a personal Chair of Clinical
Neurophysiology in 1987 at the
University of New South Wales. In 1991,
he became Professor of Neurology
and Chairman of the Department of
Neurology at Prince Henry and Prince
of Wales Hospitals, and Director of
Clinical Research at the Prince of Wales
Medical Research Institute. In 2002,
he moved to the University of Sydney
as Director of Research for Sydney
Medical School and Dean of Research &
Development (for the Health Faculties).
In 2008, he was appointed Bushell
Professor of Neurology, and continues
as Associate Dean (Research) for
Sydney Medical School. He maintains
an active research program on human
neurophysiology in The Medical
Foundation Building. Professor Burke
was elected Fellow of the Australian
Academy of Science (FAA) and Fellow
of the Australian Academy of Sciences
and Technology (FTSE) in 1995. In
1999, he was appointed Officer in
the Order of Australia (AO) and in
2003 he was awarded the Centenary
Medal of Federation by the Australian
Government.
Current Term of Appointment:
18/04/2005 to AGM 2012
Special responsibilities: Honorary
Governor
Number of meetings attended: 4,
eligible to attend: 5
Mr R A Caldwell
Qualifications and experience: Richard
Caldwell recently resigned from 25
years in investment banking in Sydney
and London to pursue a full-time role as
executive chairman of Dyesol Limited,
an ASX listed solar energy company.
In 2009, Dyesol was voted Australian
Sustainable Company of the Year. He
holds an economics degree and law
degree from the University of Sydney
and a Graduate Diploma in Applied
Finance from FINSIA. Currently he is
a director of the unlisted biomedical
device company, Aimedics Pty Ltd,
a scientific collaboration with the
University of Technology, Sydney.
Aimedics specialises in non-invasive
diagnostics for type I and insulindependent diabetes. For the past five
years he has also performed a parttime academic role with Macquarie
University where he teaches the Equity
Capital Markets elective in the Masters
degree in Applied Finance.
Current Term of Appointment:
2/05/2000 to AGM 2012
Special responsibilities: Honorary
Governor
Number of meetings attended: 3,
eligible to attend: 5
Mr J C Conde AO
Qualifications and experience: John
Conde holds B.Sc & B.E. (Hons)
degrees (with the University Medal)
from the University of Sydney and
MBA (Distinction) from Harvard
Business School. He is Chairman of
Ausgrid (formerly EnergyAustralia).
He is also Chairman of Bupa Australia,
Whitehaven Coal Limited, the Sydney
Symphony and Destination New
South Wales He is President of the
Commonwealth Remuneration Tribunal
and a Director of Dexus Property
Group. He is also Chairman of the
Dermatology Research Foundation at
the University of Sydney and of the
Australian Olympic Committee (NSW)
Fundraising Committee. He is an Officer
of the Order of Australia granted on 26
January 1994. He has previously held
executive positions in the private sector
as well as non-executive directorships
in private and public companies and
pro-bono organisations, including
Director of BHP Billiton and National
President of the National Heart
Foundation.
Current Term of Appointment: AGM
2011 to AGM 2014
Special responsibilities: Honorary
Governor
Number of meetings attended: 3,
eligible to attend: 5
Mr T Dolan
Qualifications and experience: Tim
Dolan commenced his role as Director
of Development, Development
Office, at the University of Sydney in
January 2009. He has spent his entire
professional career as a fundraiser.
For the six years prior to his coming
to Australia, Tim was responsible for
Leadership Gifts at UCLA and before
that he led the development effort for
the Medical School and Comprehensive
Cancer Centre at the University of
Hawaii.
Current Term of Appointment:
22/03/2010 to AGM 2014
Special responsibilities: Honorary
Governor
Number of meetings attended: 4,
eligible to attend: 5
Mrs B Gardiner-Hill
Qualifications and experience: Bunny
Gardiner-Hill has worked with a number
of community organisations including
the Malcolm Sargent Cancer Fund for
Children in Australia, the Australiana
Fund, the Australian Red Cross schools
program, and Prevention (later CAPS).
Mrs Gardiner-Hill is a member of the
Friends of the Sydney International
Piano Competition which welcomes
contestants to Sydney from around
the world every four years. She was
awarded Honorary Life Membership
of the Postgraduate Federation in
Medicine in 1987. Mrs Gardiner-Hill was
Honorary Secretary of Sydney Medical
School Foundation from 1982 to 1989
and a member of the Sydney Medical
School Foundation Women’s Committee
from 1968 to 1993, holding positions
of Chairman and Vice- President.
She was appointed to Council as an
Honorary Governor in 1981 and a
member of the Executive Committee
from 1994 to 1998 and from 2000 to
2004. In recognition of her long term
commitment to the University, Mrs
Gardiner-Hill was made an Honorary
Fellow of the University of Sydney in
2010.
Current Term of Appointment:
16/06/1981 to AGM 2011
Special responsibilities: Honorary
Governor
Number of meetings attended: 2,
eligible to attend: 2
Mr I Horton
Qualifications and experience: Ian has a
Commerce Degree (BCom FAICD FCIS)
from UNSW majoring in Statistics.
He is a Fellow of both the Australian
Institute of Company Directors and
the Institute of Chartered Secretaries.
He also has qualifications from the
Insurance Institute of Australia and New
Zealand and Financial Services Institute
of Australasia. From 1975 to 1998 Ian
occupied various senior positions within
the financial services and investment
management industries. In January
1992, he was appointed Managing
Director of Prudential Portfolio
Managers Australia Ltd reporting to
a main board director in the UK. Ian
also served on the company’s global
management committee from 1994 and
the board of the UK parent company
from 1996. Ian was a member of the
Board of the Australian Investment
Managers Association (AIMA) from
1993 to 1997. He was Chairman of its
Corporate Governance Committee
from 1994. From 1994 to 1997 he was
a member of the AICD Corporate
Governance Committee. In 1998, he
became an interim director of the
Investment and Financial Services
Association. In May 1999 Ian became
a founding principal in Boardroom
Partners, a company consulting in
corporate governance to boards and
also engaging in non-executive director
search. In 1999 he was appointed
to the AMP Managed Investment
Schemes Compliance Committee and
was chairman of that committee from
2002 to 2005. He currently chairs the
Compliance Committee of Apostle
Asset Management and has done so
since 2008. From 2002 until 2008
he was NSW Course Director for the
Corporate Governance subject in
the Chartered Secretaries Australia
Graduate Diploma Course. In 2008
Ian joined the board of Alzheimer’s
Australia NSW and currently chairs
its Investment Advisory Committee
and is a member of its Audit and Risk
Committee. In 2011 Ian was appointed
Chair of the Council of the Microsearch
Foundation of Australia.
Current Term of Appointment: AGM
2011 to AGM 2012
Special responsibilities: Division
Representative
Number of meetings attended: 2,
eligible to attend: 4
Ms S Jarrett
Qualifications and experience: Shauna
Jarrett holds a BA(Hons) Sydney
and an LLB(UTS). She has been a
practising solicitor for 14 years in a
range of practices. She served on the
Law Society Council for 8 years and
attained the position of Vice President.
She has also been a Director of the Arts
Law Centre, LawCover Pty Ltd and has
been a Director of the Public Interest
Advocacy Centre for 10 years, including
Chair from 2007-2010.
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: Nominee of the
DVC & Provost
Number of meetings attended: 5,
eligible to attend: 5
Mr D Kirk
Qualifications and experience: David
Kirk’s career spans the top level of
both business and sport. He has
achieved success in both the public
and private sectors. David is currently
Co-founder and Managing Partner
of Bailador Investment Management,
Chairman of the publicly listed Trade
Me and Executive Chairman of The
Hoyts Group. Prior to this, he was Chief
Executive Officer of Fairfax Media.
His previous experience also includes
time as CEO and Managing Director of
PMP Limited and a period as an advisor
to the New Zealand Prime Minister.
Earlier he worked for McKinsey & Co
in London. He is a Rhodes Scholar
with degrees in Medicine form Otago
University and Philosophy, Politics and
Economics from Oxford University. He
is currently the Chairman of Trustees
of Sydney Grammar School and sits
on a number of other Boards including
investee companies of Bailador and
charitable organisations. In the sporting
arena, David enjoyed a highly successful
rugby career playing for Otago and
Auckland and captained the All Blacks
to win the World Cup in 1987. David is
President of the New Zealand Rugby
Players Association. He was awarded an
MBE in 1987 and now lives in Sydney.
Current Term of Appointment: AGM
2011 to AGM 2014
Special responsibilities: Honorary
Governor
Number of meetings attended: 1, eligible
to attend: 4
Mr J M Millar
Qualifications and experience: James
Millar is Chair of the Smith Family and
is currently a Non Executive Director of
Mirvac Limited, Mirvac Funds Limited
and Jetset Travelworld Limited, as
well as Chair of their respective Audit
Committees. He is also a Director of the
Wynstay Pastoral Group of companies.
James is the former Area Managing
Partner and Chief Executive Officer
of Ernst & Young, and was a member
of the firms’ Global Executive Board.
His career prior to his leadership roles
at Ernst & Young was as a Corporate
Reconstruction professional. James
is a Director, Trustee or Member of a
number of not-for-profit and charitable
organisations. He has qualifications
in business and accounting, and is
a Fellow of both the Institute of
Chartered Accountants and Australian
Institute of Company Directors.
Current Term of Appointment: AGM
2011 to 22/06/2011
Special responsibilities: Honorary
Governor
Number of meetings attended: 1, eligible
to attend: 2
Professor B G Robinson
Qualifications and experience: Bruce
Robinson is an endocrinologist
and Head of the Cancer Genetics
Laboratory in the Kolling Institute. He
was appointed Dean of Sydney Medical
School in May 2007. Bruce graduated
22
GOVERNANCE STATEMENT
AND COUNCIL MEMBERS
from the University of Sydney in 1980
and then studied for his Master of
Science degree. His further molecular
research work was performed at the
Brigham and Women’s Hospital and the
Children’s Hospital, Harvard Medical
School, from 1986 to 1989 and he was
awarded a Doctorate of Medicine from
the University of Sydney in 1990. He
has developed and led the Cancer
Genetics Laboratory since 1990 and
has supervised over 20 doctoral and
masters’ students working on the
genetic basis of tumour formation
and gene therapy. He has published
over 170 peer reviewed scientific
articles. In 2003, Bruce was awarded
the Daiichi Prize by the Asia and
Oceania Thyroid Association for his
work on the pathogenesis of thyroid
cancer. Prior to his current University
appointment, Bruce was Associate
Dean (International), Sydney Medical
School at the University of Sydney and
Head of the Division of Medicine at
the Royal North Shore Hospital from
1998 to 2006. He also served on the
Council of the Endocrine Society of
Australia from 2001 to 2005, and is on
the Editorial Board of the international
journals Nature, Clinical Practice and
Endocrinology and Thyroid. Bruce is
the Founding Chairman of Hoc Mai, the
Australia Vietnam Medical Foundation,
which sponsors and supports medical,
nursing, allied health and scientific
exchanges between Australia and
Vietnam. He is also a Fellow of the
Australian Institute of Company
Directors.
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: University
Officer (Foundations): Dean, Sydney
Medical School
Number of meetings attended: 5,
eligible to attend: 5
Mr R Scheinberg
Qualifications and experience: Richard
Scheinberg has been in the property
industry for more than 20 years. He
is currently joint Managing Director
of his family group of companies,
acting for his wider family interests
as well as his own. These activities
cover many areas including real estate
investment, especially industrial and
bulky goods retailing, real estate
development, land subdivision, self
storage, property management,
tourism-related investments, marinas,
low-cost housing and medium density
residential developments. He has
also been Managing Director of
many operating businesses including
non-woven textiles, agricultural
enterprises, furniture retailing, furniture
manufacturing and soft-goods retailing.
Richard has participated in many
communal and charitable activities and
is currently a member of various boards
and committees of JCA and a Board
Member of the Education Heritage
Foundation. He is a past Board member
of the Microsearch Foundation of
Australia, Kesser Torah College and the
Yeshiva College Assistance Committee
(including its Joint Chair). Richard
joined the Council of Sydney Medical
School Foundation in 1995.
Current Term of Appointment:
15/03/1995 to AGM 2011
Special responsibilities: Honorary
Governor
Number of meetings attended: 1,
eligible to attend: 2
Dr M Williams
Qualifications and experience: Martin
Williams is a Fellow and graduate of
the Chartered Institute of Marketing.
Graduating from Macquarie Graduate
School of Management, Martin now
thrives as a member of the Faculty
of Arts and Social Sciences at the
University of Technology Sydney. He
is director of Customer Wisdom, an
affinity marketing consultancy and
Midas Interactive Pty Ltd. The latter
is dedicated to assisting parents and
teachers increase awareness and
prevention of drug-related addictions
amongst their children and students.
Martin came to Australia from Scotland
in 1981. He has been a director and
Chairman of private companies in
which he has international experience
in Asia, Australia and Europe. His direct
marketing company Cartwright Williams
Pty Ltd and CW Database Services
Pty Ltd, consulted to worldwide
corporate organisations as well as
nonprofits, were sold to US advertising
giant Leo Burnett in 2002. Martin
is author of Interactive Marketing
and was awarded Australian Direct
Marketer of the Year in 1997. Martin is
Chairman of the Salvation Army Direct
Marketing Advisory, a position he has
held since 2002. Prior to that he was
Residential Chair for the Red Shield
Appeal, Sydney. His team has helped
significantly increase funds as well as
shape the ‘Salvos’ future fundraising
and volunteer relationship strategies.
He also serves on the board of the City
of Sydney Red Shield Appeal.
Current Term of Appointment:
21/04/2008 to AGM 2012
Special responsibilities: Honorary
Governor
Number of meetings attended: 3,
eligible to attend: 5
Council members were elected at the
Foundation’s AGM on 7 March 2011.
There is a Nominations Committee of
the Foundation which reviews all new
memberships to Council. There was
not a performance evaluation of the
Council undertaken in the reporting
period.
SCIENTIFIC ADVISORY COMMITTEE
Professor C Armour
Professor D Burke
Professor J Christodoulou
Professor D Cook
Professor B Hambly
Professor D Handelsman
Professor G Mann
Professor B Robinson (Chair)
Dr C Storey
NOMINATIONS COMMITTEE
Mr R Corbett AO (until 31/10/2011)
Ms N Dolan (Chair)
Mr L Minehan
Professor B Robinson
Mr R Salteri (from 31/10/2011)
Mr R Scheinberg (until AGM 2011)
Ms L Sylvan (until 29/08/2011)
PATRONS
Mrs M H J Breekveldt
Mr P I Burrows
Sir R Crichton-Brown KCMG CBE TD
Mr B P Garrett
Mr R M Mostyn
STRUCTURE OF THE DIVISION
COUNCILS OF SYDNEY MEDICAL
SCHOOL FOUNDATION
The Councils of the Divisions of Sydney
Medical School Foundation in 2011
consisted of the following members:
AGEING AND ALZHEIMER’S
RESEARCH FOUNDATION
Professor D Le Couteur
Qualifications and experience: MBBS
Grad Cert Ed FRACP PhD
Current Term of Appointment: 2001 to
AGM 2012
Special responsibilities: Director
Number of meetings attended: 2,
eligible to attend: 3
Dr F Barr
Qualifications and experience: PhD
MHSc(Geront) BA FAICD
Current Term of Appointment: 1997 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 3,
eligible to attend: 3
Mr G Bull
Qualifications and experience: Dip Civil
Eng RMIT 1952
Current Term of Appointment: 2004 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 3,
eligible to attend: 3
Dr J Churchill
Qualifications and experience: BVSc
(Hons) Grad Dip MKT
Current Term of Appointment: 2006 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 2,
eligible to attend: 3
Dr H Creasey AM
Qualifications and experience:
MBBS(Hons1,Syd) FRACP AMusA.
Neurologist and geriatrician clinician,
researcher and educator in dementia.
Current Term of Appointment: 1994 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 2,
eligible to attend: 3
Professor R Cumming
Qualifications and experience: MBBS
MPH PhD
Current Term of Appointment: 2003 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 2,
eligible to attend: 3
Mr J Gorrie
Qualifications and experience: Retired
public servant and former Mayor of City
of Canterbury. Past member of Board
of Directors Sydney Hospital (9yrs.)
Former Chairman Sydney Eye Hospital
Advisory Committee, foundation
Chairman and Life Governor of Sydney
Eye Hospital Foundation. President of
a sport and recreation club for people
with a disability with around 1000
members from 2000.
Current Term of Appointment: 1997 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 2,
eligible to attend: 3
Ms S Jarrett
Qualifications and experience:
BA(Hons) LLB(UTS)
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: Nominee of the
DVC & Provost
Number of meetings attended: 2,
eligible to attend: 3
Professor H Kendig
Qualifications and experience: AB Calif
MPl PhD Scalif FASSA
Current Term of Appointment: 2005 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 2,
eligible to attend: 3
Professor R Lusby
Qualifications and experience:
MBBS(Hons) MD FRCS FRACS
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: University
Officer: Associate Dean & Head,
Concord Clinical School
Number of meetings attended: 2,
eligible to attend: 3
Professor A McLachlan
Qualifications and experience: BPharm
PhD FPS. Professor of Pharmacy (Aged
Care). Clinical pharmacology research
and quality use of medicines.
Current Term of Appointment: 2006 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 2,
eligible to attend: 3
Mr G E (Rusty) Priest AM
Qualifications and experience: NSW
State President and Deputy National
President of the Returned and
Services League of Australia. Member
of numerous charity committees and
boards.
Current Term of Appointment: 1995 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 0,
eligible to attend: 3
BONE AND JOINT RESEARCH
FOUNDATION
Professor D Sonnabend
Qualifications and experience: MBBS
BSc(Med) MD FRACS FA OrthA
Current Term of Appointment:
24/01/2002 to AGM 2012
Special responsibilities: President
Number of meetings attended: 1,
eligible to attend: 1
Professor D Hunter
Qualifications and experience: MBBS
MSc(Clin Epi) M SpMed PhD
FRACP(Rheum)
Current Term of Appointment: AGM
2011 to AGM 2012
Special responsibilities: Deputy
President
Number of meetings attended: 1,
eligible to attend: 1
Professor C Little
Qualifications and experience: BSc
BVMS MSc PhD Diplomate ACVS
Current Term of Appointment: 2004 to
AGM 2012
Special responsibilities: Treasurer
Number of meetings attended: 1,
eligible to attend: 1
Ms L Campbell
Qualifications and experience:
Foundation Secretary for over 15 years
Current Term of Appointment: 1991 to
AGM 2012
Special responsibilities: Secretary
Number of meetings attended: 1,
eligible to attend: 1
24
GOVERNANCE STATEMENT
AND COUNCIL MEMBERS
Ms S Jarrett
Qualifications and experience:
BA(Hons) LLB(UTS)
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: Nominee of the
DVC & Provost
Number of meetings attended: 1,
eligible to attend: 1
Professor L March
Qualifications and experience:
MBBS(Hons I) MSc PhD FRACP
FAFPHM
Current Term of Appointment: 2006 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 1,
eligible to attend: 1
Professor Jonathan Morris
Qualifications and experience:
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: University
Officer & Associate Dean and Head,
Northern
Number of meetings attended: 1,
eligible to attend: 1
Emeritus Professor T K F Taylor
Qualifications and experience:
DPhil(Oxon) FRACS
Current Term of Appointment: 1991 to
AGM 2012
Special responsibilities: Council member
Number of meetings attended: 1,
eligible to attend: 1
Dr Allan Young
Qualifications and experience: MBBS
MSpMed PhD FRACS(Orth)
Current Term of Appointment: AGM
2011 to AGM 2012
Special responsibilities: Council member
Number of meetings attended: 1,
eligible to attend: 1
DERMATOLOGY RESEARCH
FOUNDATION
The University of Sydney disestablished
the Dermatology Research Foundation
on 14/12/2011.
Mr J Conde AO
Qualifications and experience:
BSc(Distinction) BE(Hons)(Electrical)
University Medal(the University
of Sydney) Master of Business
Administration(Distinction) (Harvard
Business School)
Current Term of Appointment:
16/04/2003 to 14/12/2011
Special responsibilities: President
Number of meetings attended: 4,
eligible to attend: 4
Professor R Barnetson
Qualifications and experience: MD
FRCP FRACP FACD
Current Term of Appointment:
01/11/1988 to 14/12/2011
Special responsibilities: Director
Number of meetings attended: 4,
eligible to attend: 4
Professor D Burke AO
Qualifications and experience:
MBBS(Syd) MD DSc(UNSW) FRACP
FAA FTSE. Neurologist and Clinical
Neurophysiologist, medical research and
research governance.
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: University
Officer: Associate Dean [Research],
Sydney Medical School
Number of meetings attended: 3,
eligible to attend: 4
Clinical Professor A Cooper OAM
Qualifications and experience: BSc
MBBS FACD FAICD
Current Term of Appointment:
19/04/1991 to 14/12/2011
Special responsibilities: Council member
Number of meetings attended: 3,
eligible to attend: 4
A/Professor D Damian
Qualifications and experience:
MBBS(Hons) PhD FACD
Current Term of Appointment:
28/02/2007 to 14/12/2011
Special responsibilities: Council member
Number of meetings attended: 4,
eligible to attend: 4
Professor B Fazekas de St Groth
Qualifications and experience:
BSc(Med) MBBS PhD
Current Term of Appointment:
25/02/2009 to 14/12/2011
Special responsibilities: Council member
Number of meetings attended: 2,
eligible to attend: 4
Mr S Gorry
Qualifications and experience: BCom
LLB
Current Term of Appointment:
01/05/2004 to 14/12/2011
Special responsibilities: Council member
Number of meetings attended: 0,
eligible to attend: 4
Professor G M Halliday
Qualifications and experience:
BSc(Hons) PhD DSc. Dermatology
Researcher and Academic.
Current Term of Appointment:
15/05/2002 to 14/12/2011
Special responsibilities: Council member
Number of meetings attended: 3,
eligible to attend: 4
Ms S Jarrett
Qualifications and experience:
BA(Hons) LLB(UTS)
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: Nominee of the
DVC & Provost
Number of meetings attended: 2,
eligible to attend: 4
Mr D W Linke
Qualifications and experience: BEc
LLB. David is a partner with 15 years
experience on the transaction group at
accounting firm KPMG. He advises a
number of Australian listed companies
and foreign investors.
Current Term of Appointment:
01/09/2004 to 14/12/2011
Special responsibilities: Council member
Number of meetings attended: 1,
eligible to attend: 4
Mr A Oppenheim
Qualifications and experience:
BSc(Hons) FAICD FRACI. Director,
pharmaceutical companies 30 years,
Director: non-for-profit scientific
societies 10 years.
Current Term of Appointment:
25/02/2009 to 14/12/2011
Special responsibilities: Council member
Number of meetings attended: 1,
eligible to attend: 4
Mr P Smith
Qualifications and experience: BSc MBA
Current Term of Appointment:
13/03/2008 to 14/12/2011
Special responsibilities: Council member
Number of meetings attended: 1,
eligible to attend: 4
Ms J Stratford
Qualifications and experience: GM,
Melanoma Foundation & MASCRI 2000
– 2006; Commonwealth Government
Advisory Group 2005 Skin Cancer
Awareness Campaign.
Current Term of Appointment: February
2010 to 14/12/2011
Special responsibilities: Council member
Number of meetings attended: 3,
eligible to attend: 4
Professor W Weninger
Qualifications and experience: MD
FACD
Current Term of Appointment:
06/02/2008 to 14/12/2011
Special responsibilities: Council member
Number of meetings attended: 4,
eligible to attend: 4
ENDOCRINOLOGY AND DIABETES
RESEARCH FOUNDATION
A/Professor S M Twigg
Qualifications and experience: MBBS
PhD(Syd) FRACP
Current Term of Appointment:
01/07/2006 to AGM 2012
Special responsibilities: Director
Number of meetings attended: 2,
eligible to attend: 2
Mr J Landerer CBE AM
Qualifications and experience:
LLB(Syd.) Hon LLD(Macq.)
Current Term of Appointment:
16/08/2006 to AGM 2012
Special responsibilities: Chairman
Number of meetings attended: 2,
eligible to attend: 2
Professor W J Britton
Qualifications and experience: PhD
MBBS BScMed FRACP FRCP FRCPA
DTM&H. Bosch Professor of Medicine;
Professor of Immunology; Head,
Discipline of Medicine, Central Clinical
School, the University of Sydney; Head,
Mycobacterial Research Program,
Centenary Institute of Cancer Medicine
and Cell Biology.
Current Term of Appointment:
01/07/2006 to AGM 2012
Special responsibilities: Council member
Number of meetings attended: 2,
eligible to attend: 2
Ms S Jarrett
Qualifications and experience:
BA(Hons) LLB(UTS)
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: Nominee of the
DVC & Provost
Number of meetings attended: 2,
eligible to attend: 2
Professor C Mellis
Qualifications and experience: MBBS,
MPH, MD, FRACP (Paediatrics)
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: University
Officer: Associate Dean, Central Clinical
School
Number of meetings attended: 2,
eligible to attend: 2
Professor M McGill
Qualifications and experience: RN
MSc(med)
Current Term of Appointment:
16/08/2006 to AGM 2012
Special responsibilities: Council member
Number of meetings attended: 2,
eligible to attend: 2
E/Professor J R Turtle AO
Qualifications and experience: MD(Syd)
BS FRACP FRCP(London)
Current Term of Appointment:
01/07/2006 to AGM 2012
Special responsibilities: Council member
Number of meetings attended: eligible
to attend:
Professor D Yue
Qualifications and experience: MBBS
FRACP PhD
Current Term of Appointment:
01/07/2006 to AGM 2012
Special responsibilities: Council member
Number of meetings attended: 2,
eligible to attend: 2
MICROSEARCH FOUNDATION OF
AUSTRALIA
Mr D Stein AM
Qualifications and experience: Self
employed in specialised section of
civil construction industry for 47 years
and Past State President, National
President, and Life Member of the Civil
Contractors Federation.
Current Term of Appointment:
22/06/2006 to AGM 2012
Special responsibilities: Chair (until
AGM 2011)
Number of meetings attended: 4,
eligible to attend: 4
Mr I Horton
Qualifications and experience: BComm
FAICD FCIS
Current Term of Appointment:
11/10/2010 to AGM 2012
Special responsibilities: Chair (from
AGM 2011)
Number of meetings attended: 4,
eligible to attend: 4
Professor R Allen
Qualifications and experience: MBBS
FRACS
Current Term of Appointment:
22/06/2006 to AGM 2012
Special responsibilities: Deputy Chair
Number of meetings attended: 3,
eligible to attend: 4
Dr G A Bishop
Qualifications and experience: BScAgr
MScAgr PhD. Basic science of organ
transplantation.
Current Term of Appointment:
22/06/2006 to AGM 2012
Special responsibilities: Secretary
Number of meetings attended: 3,
eligible to attend: 4
Ms D Bozowsky
Qualifications and experience:
BA(Hons) MBA GAICD SA Fin
Current Term of Appointment:
22/06/2006 to AGM 2012
Special responsibilities: Honorary
Treasurer
Number of meetings attended: 4,
eligible to attend: 4
Professor D Burke AO
Qualifications and experience:
MBBS(Syd) MD DSc(UNSW) FRACP
FAA FTSE. Neurologist and Clinical
Neurophysiologist. Medical research
and research governance.
Current Term of Appointment:
25/02/2009 to AGM 2012
Special responsibilities: Council member
Number of meetings attended: 3,
eligible to attend: 4
Professor B Freedman
Qualifications and experience:
BSc(Med) MBBS PhD FRACP
FACC FESC FCSANZ. Professor
of Cardiology University of Sydney
26
GOVERNANCE STATEMENT
AND COUNCIL MEMBERS
Concord Hospital, Scientific Committee
Chair World Congress of Cardiology
2002, Associate Dean Central Clinical
School 1996-2000, Deputy Dean
Sydney Medical School since 2003.
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: University
Officer: Deputy Dean, Sydney Medical
School
Number of meetings attended: 4,
eligible to attend: 4
Number of meetings attended: 2,
eligible to attend: 4
Number of meetings attended: 2,
eligible to attend: 4
Professor P Maitz
Qualifications and experience:
MD(University of Vienna/Austria)
FRACS(plast surg)
Current Term of Appointment:
02/04/2009 to AGM 2012
Special responsibilities: Deputy
Chairman
Number of meetings attended: 3,
eligible to attend: 4
Mr C Hope
Qualifications and experience: BBus CA
Current Term of Appointment:
02/04/2009 to AGM 2012
Special responsibilities: Member
Number of meetings attended: 4,
eligible to attend: 4
Ms S Jarrett
Qualifications and experience:
BA(Hons) LLB(UTS)
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: Nominee of the
DVC & Provost
Number of meetings attended: 4,
eligible to attend: 4
Mr K Cranfield
Qualifications and experience: FCA
BComm CPA FFin
Current Term of Appointment:
02/04/2009 to AGM 2012
Special responsibilities: Treasurer
Number of meetings attended: 2,
eligible to attend: 4
Dr A Sharland
Qualifications and experience: MBBS
FRACP PhD
Current Term of Appointment:
22/06/2006 to AGM 2012
Special responsibilities: Council member
Number of meetings attended: 4,
eligible to attend: 4
SYDNEY BURNS FOUNDATION
The Hon J Fahey AC
Qualifications and experience: Entered
NSW Parliament in 1984 and was
appointed Minister for Industrial
Relations, Employment and Further
Education in 1988. Elected Premier
in 1992, as well as Treasurer and
Minister for Economic Development.
Entered Federal Parliament in 1996
and immediately appointed Minister
for Finance. John Fahey serves on
several Boards and in 2007 was elected
President of the World Anti-Doping
Agency.
Current Term of Appointment:
02/04/2009 to AGM 2012
Special responsibilities: Patron
Number of meetings attended: 0,
eligible to attend: 4
A/Professor P Haertsch OAM
Qualifications and experience:
MBBS(Syd) FRCS(Edin) FRACS
Current Term of Appointment:
02/04/2009 to AGM 2012
Special responsibilities: Chairman
Professor B Freedman
Qualifications and experience:
BSc(Med) MBBS PhD FRACP
FACC FESC FCSANZ. Professor
of Cardiology University of Sydney
Concord Hospital, Scientific Committee
Chair World Congress of Cardiology
2002, Associate Dean Central Clinical
School 1996-2000, Deputy Dean
Sydney Medical School since 2003.
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: University
Officer: Deputy Dean, Sydney Medical
School
Number of meetings attended: 2,
eligible to attend: 4
Ms S Jarrett
Qualifications and experience:
BA(Hons) LLB(UTS)
Current Term of Appointment: Exofficio University Councillor
Special responsibilities: Nominee of the
DVC & Provost
Number of meetings attended: 4,
eligible to attend: 4
Mr G E (Rusty) Priest AM
Qualifications and experience: NSW
State President and Deputy National
President of the Returned and
Services League of Australia. Member
of numerous charity committees and
boards.
Current Term of Appointment:
02/04/2009 to AGM 2012
Special responsibilities: Member
Number of meetings attended: 1,
eligible to attend: 4
PRINCIPLE 3 – PROMOTE ETHICAL
AND RESPONSIBLE DECISION
MAKING
Council members have been provided
with the University of Sydney
Foundation Governance Guide,
Foundation Rules, Code of Conduct,
Ms G Guthrie
External Interests Policy and the
Qualifications and experience: Journalist Occupational Health & Safety Policy.
Current Term of Appointment:
The Code of Conduct, External
02/04/2009 to AGM 2012
Interests Policy and the Occupational
Special responsibilities: Member
Health & Safety Policy are also available
Number of meetings attended: 4,
on the University’s public website as
eligible to attend: 4
are other relevant University policies
regarding gift acceptance, harassment,
Professor A J A Holland
grievance procedures and other related
Qualifications and experience:
BSc(Hons) MBBS PhD(Syd) Grad Cert policies.
Ed Studies(Higher Ed) FRCS(Eng)
FRACS(Paed) FACS. Consultant
Paediatric Surgeon and Director, The
Children’s Hospital at Westmead Burns
Research Institute.
Current Term of Appointment:
02/04/2009 to AGM 2012
Special responsibilities: Member
PRINCIPLE 4 – SAFEGUARD
INTEGRITY IN FINANCIAL
REPORTING
The annual accounts of the Foundation
are prepared by the financial staff
of the University, signed off by the
Treasurer and included in this Annual
Report to the Senate. The Foundation
is part of the University and therefore
does not have its own audit subcommittee; The University is audited by
the Audit Office of NSW.
The Foundation undertook the
following fundraising appeals during
2011: Tax Appeal and Spring Appeal.
And in conducting those appeals the
Foundation took all reasonable steps
to ensure that commissions paid or
payable to any person as part of a
fundraising appeal did not exceed
one-third of the gross money obtained
by that person in the appeal and
appropriate particulars of all items of
gross income received or receivable, all
items of expenditure incurred, including
the application or disposition of any
income obtained from the appeal and
particulars of those transactions to
which they related were recorded in the
minutes of the Foundation.
PRINCIPLE 5 – MAKE TIMELY AND
BALANCED DISCLOSURE
The Foundation complied with the
reporting and disclosure requirements
of the Senate. These include an annual
budget and this Annual Report.
Members and Council have been made
aware of the processes for disclosure
pursuant to the Code of Conduct,
Conflicts of Interest policy, which
include protected disclosure to the
ICAC, the Ombudsman or the Auditor
General.
PRINCIPLE 6 – RESPECT THE
RIGHTS OF MEMBERS, STAFF,
VOLUNTEERS, CLIENTS, & OTHER
STAKEHOLDERS
The Foundation Council consists of
members of the community, industry
bodies and the University whose
input is invited via the Annual General
Meeting and Council meetings of the
Foundation. The following meetings
have been held during the year to
involve stakeholders in election of the
Council, activities of the Foundation or
other stakeholder participation:
COUNCIL MEETINGS
5.30 pm Monday 21 February 2011
5.30 pm Monday 7 March 2011 (AGM &
Council meeting)
5.30 pm Monday 2 May 2011
5.30 pm Tuesday 16 August 2011
5.30 pm Monday 31 October 2011
SCIENTIFIC ADVISORY COMMITTEE
MEETINGS
5.00 pm Monday 7 February 2011
5.00 pm Monday 11 April 2011
5.00 pm Monday 25 July 2011
5.00pm Monday 10 October 2011
NOMINATIONS COMMITTEE
MEETINGS
5.30 pm Wednesday 9 February 2011
1.00 pm Friday 11 November 2011
Under the Charitable Fundraising Act,
the University may be questioned
about any appeal on details of the
purpose of the appeal such as the
appeal target, objectives, distribution
of proceeds, etc and the process to
provide answers. During the year the
Foundation published information on its
website and outlines those activities in
this annual report. Other enquiries may
have been made to other parts of the
University.
PRINCIPLE 7 – RECOGNISE AND
MANAGE RISK
The Foundation recognises its activities
within University premises or other
premises require risks such as health
and safety, environmental protection,
privacy, trade practices, and compliance
with the Charitable Fundraising Act
to be considered and managed. The
Foundation has managed these risks
during the year by following to the
best of its knowledge the following
University policies; Code of Conduct,
Occupational Health & Safety, Equity
& Diversity, Conflicts of Interest,
Corruption Prevention and the
University Privacy Policy.
PRINCIPLE 8 – REMUNERATE
FAIRLY AND RESPONSIBLY
No member of a Council is entitled to
receive any remuneration for acting
in that capacity except reasonable
remuneration on a basis which has
first been approved in writing by the
University Officer (Foundations).
Members of the Foundation Council
may be reimbursed for reasonable
expenses after written approval of the
University Officer (Foundations). Any
such instances are recorded in the
minutes of the Council.
28
PUBLICATIONS
SYDNEY MEDICAL SCHOOL
FOUNDATION
Professor Thomas Becker
Becker TS, Rinkwitz S. Zebrafish as a
genomics model for human neurological
and polygenic disorders. Developmental
Neurobiology 2011; 72(2).
Labalette C, Bouchoucha YX, Wassef
MA, Gongal PA, Le Men J, Becker
TS, Gilardi-Hebenstreit P, Charnay
P. Hindbrain patterning requires finetuning of early krox20 transcription
by Sprouty4. Development 2011;
138(2):317-26.
Rinkwitz S, Mourrain P, Becker TS.
Zebrafish: an integrative System for
Neurogenomics and Neurosciences.
Progressive Neurobiology 2011;
93(2):231-43.
Sundström E, Komisarczuk AZ, Jiang
L, Golovko A, Navratilova P, Rinkwitz S,
Becker TS, Andersson L. Identification
of a melanocyte-specific, MITFdependent regulatory element in the
intronic duplication causing hair greying
and melanoma in horses. Pigment Cell
Melanoma Research. 2011.
Dr Daniel Brown
Brown DB, Gibson WPR. On the
differential diagnosis of Ménière’s
disease using low-frequency acoustic
biasing of the 2f1-f2 DPOAE. Hearing
Research 2011; 282: 119-127.
Dr Clara Chow
Chow CK. Commentary: Adding
omeprazole to clopidogrel reduced GI
events and did not increase CV events.
Annals of Internal Medicine March 2011;
15:154(6).
Chow CK, Devereaux PJ. The optimal
timing of smoking cessation before
surgery. Archives of Internal Medicine
2011; 171(11): 989-990.
Chow CK, Patel A. Cardiovascular
healthcare for women in India. Heart
2011; 6(4):21-5.
Yusuf S, Islam S, Chow CK, Rangarajan
S, Dagenais G, Diaz R, Gupta
Devereaux P, Kavsak P, Walsh M,
R, Kelishadi R, Iqbal R, Avezum A,
Srinathan S, Thorlacius L, Lurati-Buse
G, Botto F, Pettit S, McQueen M, Hill S, Kruger A, Kutty R, Lanas F, Lisheng
Thomas S, Mrkobrada M, Alonso-Coello L, Wei L, Lopez-Jaramillo P, Oguz
P, Berwanger O, Biccard B, Cembrowski A, Rhaman O, Swidan H, Yusoff K,
Zatonski W, Rosengren A, and Teo
G, Chan M, Chow C, de Miguel A,
KK. Use of secondary prevention
Garcia M, Graham M, Jacka M, Kueh
drugs
for cardiovascular disease in the
J, Li S, Lit L, Martinez-Bru C, Naidoo P,
community
in high-income, middleNagele P, Pearse R, Rodseth R, Sessler
income,
and
low-income countries
D, Sigamani A, Szczeklik W, Tiboni M,
(the
pure
study):
a prospective
Carlos-Villar J, Wang C, Xavier D. High
epidemiological
survey.
Lancet 2011;
sensitivity troponin T concentrations in
(11):61215-4.
patients undergoing noncardiac surgery:
a prospective cohort study. Clinical
Associate Professor Qihan Dong
Biochemistry 2011; 44(12):1021-4.
Yao M, Xie C, Constantine M, Hua S,
Gasevic D, Vukmirovich I, Yusuf S, Teo
Hambly BD, Jardine G, Sved P, Dong
K, Chow CK, Dagenais G, Lear SA. A
Q. How can food extracts consumed
direct assessment of “obesogenic”
in the Mediterranean and East Asia
built environments challenges
suppress prostate cancer proliferation?
and recommendations. Journal of
British Journal of Nutrition 2011; 9:1-7.
Environment and Public Health 2011;
161574.
Dr Gemma Figtree
Joshi R, Chow CK, Raju PK, Raju
KR, Gottumukkala AK, Reddy KS,
MacMahon S, Heritier S, Li Q, Dandona
R, Neal B. The Rural Andhra Pradesh
Cardiovascular Prevention Study
(RAPCAPS): a cluster randomized trial.
Journal of the American College of
Cardiology. 2011.
Bibert S, Liu CC, Figtree GA, Garcia A,
Hamilton EJ, Marassi FM, Sweadner
KJ, Cornelius F, Geering K, Rasmussen
HH. . FXYD proteins reverse inhibition
of the Na+-K+ pump mediated by
glutathionylation of its beta 1 subunit.
Journal of Biology and Chemisty 2011;
286( 21): 18562-18572.
Joshi R, Praveen D, Chow C, Neal B.
Effects on the estimated cause specific
mortality fraction of providing physician
reviewers with different formats of
verbal autopsy data. Population Health
Metrics 2011; 9(33): 1-7.
Figtree GA, Lønborg J, Grieve SM,
Ward MR, Bhindi R. State of the Art
Review: Cardiac Magnetic Resonance
Imaging for the Interventional
Cardiologist. Journal of the American
College of Cardiology: Cardiovascular
Interventions 2011; Feb;4(2):137-48.
Mir H, Buchanan D, Gilmore A, McKee
M, Yusuf S, Chow CK. Cigarette pack
labeling in 12 countries at different
levels of economic development.
Journal of Public Health Policy (In
press).
Wood A, Pell J, Patel A, Neal B, Raju K,
Chow CK. Prevention of cardiovascular
disease in a rural region of India and
strategies to address the unmet need.
Heart 2011; 97(17):1373-8.
Hamilton EJ, Figtree GA, Rasmussen
HH. Consideration of Natriuretic
Peptide Receptor C. Circulation
Research 2011; Feb, 18; 108(4); e4-e4.
Ho E, Bhindi R, Ashley EA, Figtree
GA. Genetic analysis in cardiovascular
disease: a clinical perspective.
Cardiology in Review 2011; Mar-Apr
19(2):81-9.
Kanagaratnam L, Lee A, Whalley D,
Figtree GA. Overcoming artefacts and
fears: an EP study and radiofrequency
ablation in a Parkinsonian patient
with SVT and a brain neurostimulator.
Pacing and Clinical Electrophysiology
2011.
Karimi-Galougahi K, Harden M, Maher
R, Gill A, Bhindi R, Grieve SM, Brady
P, Figtree GA. Incremental diagnostic
value of magnetic resonance imaging in
the characterisation of a cardiac mass
2011. Journal of the American College
of Cardiology; 30: 58(10): e19.
Karimi-Galougahi K, Grieve SM,
Figtree GA. “Case Challenge: MRI
for Assessment of a Cardiac Mass.”
CardioSource.org. 2011.
Yan W, Ward MR, Nelson G, Figtree GA,
Bhindi R. Overcoming limited depth
penetration of Optical Coherence
Tomography using wire bias. Journal
of the American College of Cardiology:
Cardiovascular Interventions. (In press:
Accepted September, 2011).
Yu CY, Grieve SM, Bhindi R, Figtree
GA. Post-infarct ventricular thrombus:
a critical diagnosis made by cardiac
magnetic resonance. Heart, Lung, and
Circulation 2011; 20(6):372-3.
Professor Jennifer Gamble
Gamble JR, Vadas MA, McCaughan,
G. Sinusoidal Endothelium is Essential
for Liver Regeneration. Hepatology
Elsewhere 2011; 54(2):731-3.
Nguyen LS, Jolly L, Shoubridge
C, Chan WK, Huang L, Laumonnier
F, Raynaud M, Hackett AA, Field M,
Rodriguez J, Srivastava AK, Lee Y, Long
R, Addington AM, Rapoport JL, Suren
S, Hahn CN, Gamble J, Wilkinson MF,
Corbett MA, Gecz J. Transcriptome
profiling of UPF3B/NMD-deficient
lymphoblastoid cells from patients with
various forms of intellectual disability.
Mol Psychiatry 2011; Dec 20 doi:
10.1038/mp.2011.163. [Epub ahead of
print]
24.
Bhala N, Angulo P, van der Poorten
D, Lee E, Hui JM, Saracco G, Adams
LA, Charatcharoenwitthaya P, Topping
JH, Bugianesi E, Day CP, George J. The
natural history of nonalcoholic fatty
liver disease with advanced fibrosis or
cirrhosis: An international collaborative
study. Hepatology. 2011;54:1208-16.
Booth D, Ahlenstiel G, O’Conner K, G
Stewart, George J. Improved IL28B
SNPs and haplotypes for prediction of
drug response in treatment of hepatitis
C using massively parallel sequencing
in a cross-sectional European cohort.
Genome Medicine 2011;8:57.
Gidding H, Law MG, Amin J, Macdonald
G, Sasadeusz J, Jones T, Strasser S,
George J, Dore G on behalf of the
ACHOS investigator team. Predictors
of hepatitis C treatment deferral in
Australian clinics. Medical Journal of
Australia 2011;194:398-402.
Hebbard L, George J. Animal Models
of Fatty Liver Disease. Nature Reviews
Gastroenterology and Hepatology 2011
Jan;8(1):35-44.
Jacobson I, McHutchison JG, Dusheiko
G, Di Bisceglie AM, Reddy R, Bzowej N,
Marcellin P, Muir AJ, Ferenci P, Flisiak
R, George J, Rizzetto M, Shouval D,
Sola R, Terg RA, Yoshida EM, Adda N,
Bengtsson L, Sankoh AJ, Kieffer TA,
George S, Kauffman RS, Zeuzem S for
the ADVANCE Study Team. Telaprevir
for Previously Untreated Chronic
Hepatitis C Infection. New England
Journal of Medicine 2011;364:2405-16.
Johnson NA, Keating SE, George J.
Exercise and the Liver: Implications
for therapy in fatty liver disorders.
Seminars in Liver Disease 2011
(Accepted for print 12/10/11).
Expression in Hepatic Stellate Cells
by an Interleukin 6-Department
Mechanism. Alcohol Clin Exp Res
2011;35:921-928.
Mahady S, Webster A, Walker S,
Sanyal A, George J. The role of
thiazolidinediones in non-alcoholic
steatohepatitis- a systematic
review and meta analysis. Journal of
Hepatology 2011 Dec;55(6):1383-90.
Park G, Wiseman E, George J, Katelaris
PH, Seow F, Fung C, Ngu MC. Noninvasive Estimation of Liver Fibrosis
in Non-Alcoholic Fatty Liver Disease
Using the 13C-Caffeine Breath Test.
Journal of Gastroenterology and
Hepatology 26 (2011) 1411–1416.
Patterson SJ, George J, Strasser SI,
Lee AU, Sievert W, Nicoll AJ, Desmond
PV, Roberts SK, Locarnini S, Bowden
S, Angus PW. Tenofovir disoproxil
fumarate rescue therapy following
failure of both lamivudine and adefovir
dipivoxil in chronic Hepatitis B. Gut
2011;60 247-254.
Pattullo V, Douglas MW, George J.
Organelle Dysfunction in Hepatitis
C Virus-Associated Steatosis;
Anything to Learn from Nonalcoholic
Steatohepatitis? Expert Reviews
Gastroenterology and Hepatology
2011;5:265-277
Pattullo V, George J. The problem
of insulin resistance and its effect
on therapy. Advanced Therapy for
Hepatitis C Infection 2010, Section 2,
Chapter 23 (In print, 29/06/2011).
Poustchi H, Farrell G, Strasser S,
McCaughan G, Lee A, George J.
Feasibility of conducting a randomised
control trial for liver cancer screening:
Is a randomised controlled trial for
liver cancer screening feasible or still
needed? Hepatology 2011.
Professor Jacob George
Johnson NA, van Overbeek D, Chapman
PG, Thompson MW, Sachinwalla T,
Parker HM, Johnson NA, Burdon
George J. Effect of prolonged exercise
CA, Cohn JS, O’Connor HT, George
and pre-exercise dietary manipulation
J. Omega-3 Supplementation and
on hepatic triglycerides in trained men.
Non-Alcoholic Fatty Liver Disease: A
European Journal of Applied Physiology Systematic Review and Meta-analysis.
2011 (Accepted 29th August 2011).
Journal of Hepatology 2011.
Ahlenstiel G, Booth DR, George J.
Clinical significance of IL28B gene
variation in hepatitis C virus infection.
Hot Topics in Viral Hepatitis 2011;7:17-
Liu Y, Brymora J, Zhang H, Smith
B, Ramezani-Moghadam M, George
J, Wang J. Leptin and Acetaldehyde
Synergistically Promotes αSMA
Poustchi H, George J, Esmaili S,
Esna-Ashari F, Ardalan G, Sepanlou
SG, Alvarian SM. Gender Differences
of Healthy Ranges for Serum Alanine
30
PUBLICATIONS
Aminotransferase Level in Adolescence.
PLoS ONE 2011;6:e21178.
SC Raftopoulos, George J, Bourliere
M, Rossi E, de Boer WB, Jeffrey GP,
Bulsara M, Speers DJ, MacQuillan
G, Ching HLI, Kontorinis N, Cheng W,
Flexman J, Fermoyle S, Rigby P, Walsh
L, McLeod D. Adams LA. Comparison
of Non-Invasive Models of Fibrosis
in Chronic Hepatitis B. Hepatology
International 2011.
Suppiah V, Gaudieri S, Armstrong
N, O’Connor KS, Berg T, Weltman M,
Abate ML, Spengler U, Bassendine
M, Dore GJ, Irving WL, Powell E,
Hellard M, Riordan S, Matthews G,
Sheridan D, Nattermann J, Smedile A,
Muller T, Hammond E, Dunn D, Negro
F, Bochud PY, Mallal S, Ahlenstiel G,
Stewart GJ, George J, Booth DR for
the International Hepatitis C Genetics
Consortium. IL28B, HLA-C and KIR
variants additively and interactively
predict response to therapy in chronic
hepatitis C Virus infection. PLoS
Medicine 2011;8:e1001092.
1-9.
Little M, Gordon J, Markham P,
Rychetnik L, Kerridge I. Virtuous acts
as practical medical ethics: an empirical
study. Journal of Evaluation in Clinical
Practice 2011; 17(5): 948-953.
Little M, Lipworth W, Gordon J,
Markham P, Kerridge I. Another
argument for values-based medicine.
The International Journal of Person
Centered Medicine (In press).
Little M, Lipworth M, Gordon J,
Markham P, Kerridge I. Values-based
medicine and modest foundationalism.
Journal of Evaluation in Clinical
Practice (In press).
Professor Kathryn North
Ardern-Holmes S, North KN.
Therapeutics for Childhood
Neurofibromatosis. Current Treatment
Options in Neurology 2011; 13(6):529543.
Au CG, Butler TL, Sherwood MC, Egan
JR, North KN, Winlaw D. Increased
connective tissue growth factor
Thein HH, Walter SR. Gidding H, Amin J,
associated with cardiac fibrosis in
Law MG, George J, Dore GJ. Trends in
the mdx mouse model of dystrophic
incidence of hepatocellular carcinoma
cardiomyopathy. International Journal
after diagnosis of Hepatitis B or C
of Experimental Pathology 2011;
infection: A Population-Based Cohort
92(1):57-65.
Study, 1992 – 2007. Journal of Viral
Bray P, Bundy AC, Ryan MM, North
Hepatitis 2011;18:e232-241.
KN, Burns, J. Health status of boys
Walter S, Thein HH, Amin J, Gidding
with Duchenne muscular dystrophy:
H, Ward K, Law MG, George J, Dore
A parent’s perspective. Journal of
G. Trends in mortality after diagnosis of
Paediatrics and Child Health 2011;
Hepatitis B or C infection: 1992-2006.
47(8):557-562.
Journal of Hepatology 2011;54:879-886.
Chan S, Seto JT, Houweling P, Yang N,
Walter SR, Thein HH, Gidding HF,
North KN, Head SI. Properties of EDL
Amin J, Law MG, George J, Dore
muscle and skinned fibers from adult
GJ. Risk factors for hepatocellular
and aged male and female Actn3 KO
carcinoma in a cohort infected with
mice. Muscle Nerve 2011; 43(1):37-48.
hepatitis B or hepatitis C. Journal of
Waddell LB, Lemckert FA, Zheng XF,
Gastroenterology and Hepatology
Tran
J, Evesson FJ, Hawkes JM, Lek A,
2011 May 26. doi: 10.1111/j.1440Street
NE, Lin P, Clarke NF, Landstrom
1746.2011.06785.x.
AP, Ackerman MJ, Weisleder N, Ma
Professor Ian Kerridge
J, North KN, Cooper ST. Dysferlin,
annexin A1, and mitsugumin 53 are
Little M, Gordon J, Markham P,
upregulated in muscular dystrophy
Lipworth W, Kerridge, I. Making
and localize to longitudinal tubules of
decisions in the mechanistic,
the T-system with stretch. Journal
probabilistic and scientific domains of
of
Neuropathy and Experimental
medicine: a qualitative study of medical
Neurology
2011; 70(4):302-13.
practitioners. The International Journal
of Person Centered Medicine 2011; 1(2):
Fitzsimons, DA, Jones DL, Barton
B, North KN. A procedure for the
computerized analysis of cleft palate
speech transcription. Clinical Linguistics
and Phonetics 2011; 26(1):18-38.
Huson SM, Acosta MT, Belzberg AJ,
Bernards A, Chernoff J, Cichowski
K, Gareth Evans D, Ferner RE,
Giovannini M, Korf BR, Listernick
R, North KN, Packer RJ, Parada
LF, Peltonen J, Ramesh V, Reilly KM,
Risner JW, Schorry EK, Upadhyaya
M, Viskochil DH, Zhu Y, HunterSchaedle K, Giancotti FG. Back to the
future: Proceedings from the 2010
NF Conference. American Journal
of Medical Genetics (Part A) 2011;
155:307-321.
Kalamarides M, Acosta M, BabovicVuksanovic D, Carpen O, Cichowski
K, Evans G, Giancotti F, Hanemann O,
Ingram D, Lloyd A, Mayes D, Messiaen
L, Morrison H, North KN, Packer
R, Pan P, Stemmer-Rachamimov A,
Upadhyaya M, Viskochil D, Wallace
MR, Hunter-Schaedle K, Ratner
N. Neurofibromatosis 2011: A
Report of the Children’s Tumour
Foundation Annual Meeting. Acta
Neuropathological; [Epub November
2011].
Koutsopoulos OS, Koch C, Tosch
V, Böhm J, North KN, Laporte J.
Differential impact of dynamin 2
mutations associated to centronuclear
myopathy and Charcot-Marie-Tooth
peripheral neuropathy. PLoS ONE 2011;
6(11):e27498.
Lek A, Evesson FJ, Sutton RB, North
KN, Cooper ST. Ferlins; regulators
of vesicle fusion for auditory
neurotransmission, receptor trafficking
and membrane repair. Traffic [Epub
August 2011].
Lo HP, Bertini E, Mirabella M, Dale RC,
Petrini S, D’Amico A, Valente EM, Tozzi
G, Tasca G, Cooper ST, Straub V, North
KN.. Mosaic caveolin-3 expression
in acquired rippling muscle disease
without evidence of myasthenia
gravis or acetylcholine receptor
autoantibodies. Neuromuscular
Disorders 2011; 21:194-203.
London K, Moharir M, HowmanGiles R, North KN. Children with
Neurofibromatosis type 1: Positron
Emission Tomography. Tumors of the
Central Nervous System (In press)
Menezes MP, North KN. Inherited
Neuromuscular Disorders: Pathways to
Diagnosis. Journal of Paediatric and
Child Health; [Epub Novemember 2011].
DG, Raftery JM, Yang N, Head S,
North KN. Deficiency of α-actinin-3 is
associated with increased susceptibility
to contraction-induced damage and
skeletal muscle remodelling. Human
Molecular Genetics 2011; 20:2914-2927.
Waddell LB, Lemckert F, Zheng XF,
Menezes MP, Waddell LB, Evesson FJ,
Tran
J, Evesson FJ, Hawkes J, Lek A,
Cooper ST, Webster R, Jones K, Mowat
Street
N, Lin P, Clarke NF, Ackerman
D, Johnston HM, Corbett A, Harbord M,
M,
Weisleder
N, Ma J, North KN,
North KN, Clarke NF. The importance
Cooper
ST,
Payne
JM, Hyman SL,
and challenge of making an early
Shores
EA,
North
KN.
Assessment of
diagnosis in LMNA-related muscular
Executive Function and Attention in
dystrophies. Neurology.
Children with Neurofibromatosis Type
Nguyen MT, Joya JE, Kee AJ,
1: Relationships between Cognitive
Domazetovska A, Yang N, Hook JW,
Measures and Real-World Behaviour.
Lemckert FA, Kettle E, Valova VA,
Child Neuropsychology; 22:1-17.
Robinson PJ, North KN, Gunning
Waddell LB, Monnier N, Cooper
PW, Mitchell CA, Hardeman EC.
ST, North KN, Clarke NF. Using
Hypertrophy and dietary tyrosine
complementary
cDNA from MyoDameliorate the phenotypes of a mouse
transduced
fibroblasts
to sequence
model of severe nemaline myopathy.
large muscle genes. Muscle Nerve
Brain [Epub November 2011].
2011; 44(2):280-282.
Ravenscroft G, Sollis E, Charles AK,
Waddell LB, Tran J, Zheng XF,
North KN, Baynam G, Laing NG. The
Bonnemann CG, Evesson FJ, Arbuckle
molecular genetics of monogenic
S,
Wang M, Smith RLL, North
neuromuscular disorders characterised
KN,
Clarke NF. A study of FHL1,
by reduced foetal movement. Journal
BAG3,
MATR3, PTRF and TCAP in
of Medical Genetics [Epub October
Australian
muscular dystrophy patients.
2011].
Neuromuscular Disorders 2011;
Ravenscroft G, Sollis E, Charles AK,
21(11):776-781.
North KN, Baynam G, Laing NG. Foetal
Wang D, Nykanen M, Yang N, Winlaw
akinesia – review of the genetics of
David, North KN, Verkman AS, Owler
the neuromuscular causes. Journal of
Medical Genetics 2011; 48(12):7930801 BK. Altered cellular localisation
of aquaporin-1 in experimental
Pistilli EE, Bogdanovich S, Garton F,
hydrocephalus in mice and reduced
Yang N, Gulbin J, Conner J, Anderson
ventriculomegaly in aquaporin-1
BG, Quinn LS, North K, Ahima RS,
deficiency. Molecular and Cellular
Khurana TS. Loss of Interleukin-15Rα
Neuroscience 2011; 46(1):318-24.
Alters Endurance, Fatigability and
Yiu E, Klausegger A, Waddell L, Grasern
Metabolic Characteristics of Fast
N, Lloyd L, Tran K, North KN, Bauer
Skeletal Muscles. Journal of Clinical
JW,
Chow CW, Ryan MM, Murrell
Investigation 2011; 121(8):3120-3132.
DF. Epidermolysis bullosa with
Sangster J, Shores EA, Watt S, North
late-onset muscular dystrophy and
KN. The cognitive profile of preschoolplectin deficiency. Muscle Nerve 2011;
aged children with Neurofibromatosis
44(1):135-41.
type 1. Child Neuropsychology 2011;
Yang N, Schindeler A, McDonald MM,
17:1-16.
Seto JT, Houweling PJ, Lek M, Hogarth
Seto JT, Chan S, Quinlan KG, Turner N, M, Morse A, Raftery JM, Balasuriya
Cooney GJ, Head S, Yang N, North KN. D, MacArthur DG, Berman Y, Quinlan
The effect of α-actinin-3 deficiency
K, Eisman JA, Nguyen TV, Center JR,
on muscle ageing. Experimental
Prince RL, Wilson SG, Zhu K, Little
Gerontology 2011; 46:292-302.
DG, North KN. α-actinin-3 deficiency
is associated with reduced bone mass
Seto JT, Lek M, Quinlan KGR,
in human and mouse. Bone 2011;
Houweling P, Zheng F, MacArthur
49(4):790-798.
Wang CH, Dowling JJ, North
KN, Schroth MK, Sejersen T, et al.
Consensus Statement on Standard
of Care for Congenital Myopathies.
Pediatric Neurology (In press).
Professor Tania Sorrell
Ferguson PE, Gilroy NM, Sloots
TP, Nissen MD, Dwyer DE, Sorrell
TC. Evaluation of a clinical scoring
system and directed laboratory
testing for respiratory virus infection
in hematopoietic stem cell transplant
recipients. Transplant Infectious
Diseases 2011; 13: 448-455.
Konstantinos A, Simpson G, Sorrell TC,
Marais BJ. Doing the right thing for
tuberculosis control in the Torres Strait
Islands. Medical Journal of Australia
2011; 195:512.
Ngamskulrungroj P, Price J, Sorrell TC,
et al. The Cryptococcus gattii virulence
composite: candidate genes revealed
by micro-array analysis of higher and
less virulent Vancouver Island outbreak
strains. PLOS One 2011; 6:(1) e16076.
Zuo X, Djordjevic JT, Oei Bijosono
J, Desmarini D, Schibeci SD, Jolliffe
KA, Sorrell TC. Miltefosine Induces
Apoptosis-like Cell Death in Yeast
via Cox9p in Cytochrome c Oxidase.
Molecular Pharmacology; 80(3) (In
press).
Professor Kate Steinbeck
Ayer JG, Harmer JA, Steinbeck
K, Celermajer D. Severe Obesity Is
Associated With Impaired Arterial
Smooth Muscle Function in Young
Adults. Obesity 2011; 19: 54-60.
Cheng HL, Bryant C, Cook R, O’Connor
H, Rooney R, Steinbeck, K. The
relationship between obesity and
hypoferraemia in adults: a systematic
review. Obesity Reviews [Epub October
2011].
Magarey AM, Perry RA, Baur LA,
Steinbeck KS, Sawyer M, Hills AP,
Wilson G, Lee A, Daniels LA. A parentled family-focused treatment program
for overweight children aged 5 to 9
years: the PEACH RCT. Paediatrics
2011; 127(2):214-22.
32
PUBLICATIONS
O’Connor H, Munas Z, Griffin H, Rooney Hodge C, Sutton GL, Lawless MA,
K, Cheng HL, Steinbeck K. Nutritional
Rogers CM, Chan CC . A comparison
adequacy of energy restricted diets
of Photorefractive Keratectomy
for young obese women. Asia Pacific
and LASIK procedures following
Journal of Clinical Nutrition 2011;
Corneal Transplantation. Journal of
20(2):206-211.
Cataract and Refractive Surgery 2011;
37(1):1884-1894.
Perry L, Lowe JM, Steinbeck KS,
Dunbabin JS. Services doing the best
they can: service experiences of young
adults with type 1 diabetes mellitus
in rural Australia. Journal of Clinical
Nursing [Accepted October 2011].
Kim P, Sutton GL, Rootman DS .
Applications of the Femtosecond
Laser in Corneal Refractive Surgery,
Current Opinion in Ophthalmology 2011;
22(4):238-244.
Purtell L, Sze L, Loughnan G, Smith E,
Herzog H, Sainsbury-Salis A, Steinbeck
K, Campbell L, Viardot A. In adults
with Prader-Willi Syndrome, elevated
ghrelin levels are more consistent with
hyperphagia than elevated PYY and
GLP-1 levels. Neuropeptides 2011: 45
(4):301-307.
Roberts T, Lawless M, Sutton G,
Bali Jindal S, Hodge C. Capsular
Block Syndrome Associated with
Femtosecond Cataract Surgery. Journal
of Cataract & Refractive Surgery 2011;
37(11):2068-2070.
Shrewsbury VA, Nguyen B, O’Connor
J, Steinbeck KS, Lee A, Hill AJ, Shah
S, Kohn MR, Torvaldsen S, Baur LA.
Short-term outcomes of communitybased adolescent weight management:
The Loozit® Study. BMC – Pediatrics
2011;11:13.
Sze L, Purtell L, Jenkins A, Loughnan
G, Smith E, Herzog H, Sainsbury A,
Steinbeck K, Campbell LV, Viardot A.
Effects of a Single Dose of Exenatide
on Appetite, Gut Hormones, and
Glucose Homeostasis in Adults with
Prader-Willi Syndrome. Journal of
Clinical Endocrinology and Metabolism
2011; 96:e1314-1319.
West C, Brodie L, Dicker J, Steinbeck
K. Development of Health Support
Services for Adults with Spina Bifida.
Disability and Rehabilitation 2011;
33:2381-2388.
Professor Gerard Sutton
Hodge C, Bali-Jindal S, Chan CC,
Jacobs M, Chen S, Ng D, Roberts
T, Sutton G, Hughes P, Lawless M .
Introduction of Femtosecond Laser to
Cataract Practice. Saudi Journal of
Ophthalmology (Accepted November
2011).
Hodge C, Lawless M, Sutton G.
Keratectasia following LASIK in a
patient with uncomplicated PRK in the
fellow eye. Journal of Cataract and
Refractive Surgery 2011; 37(3):603-7.
DIVISIONS
AGEING AND ALZHEIMER’S
RESEARCH FOUNDATION
Barker A, Brand C, Haines T, Hill K,
Brauer S, Jolley D, Botti M, Cumming
R, Livingston P M, Sherrington C,
Zavarsek S, Morello R, Kamar J. The
6-PACK programme to decrease
fall-related injuries in acute hospitals:
protocol for a cluster randomised
controlled trial. Injury Prevention 2011;
17:(4),e5.
Bartlett BJ, Isakson P, Lewerenz J,
Sanchez H, Kotzebue RW, Cumming
RC, Harris GL, Nezis IP, Schubert DR,
Simonsen A, Finley KD. Ref(2)P and
ubiquitinated proteins are conserved
markers of neuronal aging, aggregate
formation and progressive autophagic
defects. Autophagy 2011; 7:(6),572-83.
Benseler V, Warren A, Vo M, Holz
LE, Tay SS, Le Couteur DG, Breen E,
Allison AC, van Rooijen N, McGuffog C,
Schlitt HJ, Bowen DG, McCaughan GW,
Bertolino P. Hepatocyte entry leads
to degradation of autoreactive CD8
T cells. Proceedings of the National
Academy of Sciences of the USA 2011;
108:(40),16735-40.
Bleicher K, Cumming RG, Naganathan
V, Seibel MJ, Sambrook PN, Blyth
FM, Le Couteur DG, Handelsman
DJ, Creasey HM, Waite LM. Lifestyle
factors, medications, and disease
influence bone mineral density in older
men: findings from the CHAMP study.
Osteoporosis International 2011; 22:(9),
2421-37.
Bleicher K, Cumming RG, Naganathan
V, Travison TG, Sambrook PN, Blyth FM,
Handelsman DJ, Le Couteur DG, Waite
LM, Creasey HM, Seibel MJ. The role of
fat and lean mass in bone loss in older
men: Findings from the CHAMP study.
Bone [Epub ahead of print].
Blyth FM, Cumming RG, Nicholas MK,
Creasey H, Handelsman DJ, Le Couteur
DG, Naganathan V, Sambrook PN,
Seibel MJ, Waite LM. Intrusive pain and
worry about health in older men: the
CHAMP study. Pain 2011; 152:(2),44752.
Brock K, Clemson L, Cant R, Ke L,
Cumming RG, Kendig H, Mathews
M. Worry in older community-residing
adults. International Journal of Ageing
and Human Development 2011;
72:(4),289-301.
Chen JS, Cameron ID, Simpson JM,
Seibel MJ, March LM, Cumming RG,
Lord SR, Sambrook PN. Low-trauma
fractures indicate increased risk of hip
fracture in frail older people. Journal
of Bone and Mineral Research 2011;
26:(2),428-33.
Clifton-Bligh RJ, Nguyen TV, Au
A, Bullock M, Cameron I, Cumming
R, Chen JS, March LM, Seibel MJ,
Sambrook PN. Contribution of a
common variant in the promoter of the
1-alpha-hydroxylase gene (CYP27B1)
to fracture risk in the elderly. Calcified
Tissue International 2011; 88:(2),109-16.
Dolton MJ, McLachlan AJ. Clinical
importance of the CYP2C19*17 variant
allele for voriconazole. British Journal of
Clinical Pharmacology 2011; 71:(1),137-8.
Giam JA, McLachlan AJ, Krass
I. Characterising specialized
compounding in community pharmacies.
Research in Social and Administrative
Pharmacy [Epub ahead of print].
Giam JA, McLachlan AJ, Krass I.
Community pharmacy compoundingimpact on professional status.
International Journal of Clinical
Pharmacology 2011; 33:(2),177-82.
Gnjidic D, Bell JS, Hilmer SN, Lonnroos
E, Sulkava R, Hartikainen S. Drug
Burden Index associated with function
in community-dwelling older people in
Finland: A cross-sectional study. Annals
of Medicine [Epub ahead of print].
Gnjidic D, Le Couteur DG, Abernethy
DR, Hilmer SN. Reducing drugs in older
adults is more. Archives of Internal
Medicine 2011;171:(9),868-9.
Gnjidic D, Le Couteur DG, Abernethy
DR, Hilmer SN. Drug Burden Index and
Beers Criteria: Impact on Functional
Outcomes in Older People Living in
Self-Care Retirement Villages. Journal
of Clinical Pharmacology [Epub ahead
of print].
Hairi NN, Bulgiba A, Cumming RG,
Naganathan V, Mudla I. Depressive
symptoms, visual impairment, and
its influence on physical disability
and functional limitation. Journal of
the American Geriatric Society 2011;
59:(3),557-9.
He X, Clarke SJ, McLachlan AJ. Clinical
pharmacology of chemotherapy agents
in older people with cancer. Current
Gerontology and Geriatrics Research;
628670.
Hilmer SN, Gnjidic D, Abernethy
DR. Pharmacoepidemiology in the
Postmarketing Assessment of the
Safety and Efficacy of Drugs in Older
Adults. The Journals of Gerontology
Series A: Biological Sciences and
Medical Sciences [Epub ahead of print].
Series A: Biological Sciences and
Medical Sciences 2011; 66:(3),264-78.
Le Couteur DG, Benson VL, McMahon
AC, Blyth F, Handelsman DJ, Seibel MJ,
Kennerson M, Naganathan V, Cumming
RG, de Cabo R. Determinants of serum- Mitchell SJ, Huizer-Pajkos A, Cogger
induced SIRT1 expression in older
VC, McLachlan AJ, Le Couteur DG,
men: the CHAMP study. The Journals
Jones B, de Cabo R, Hilmer SN. Ageof Gerontology Series A: Biological
related pseudocapillarization of the
Sciences and Medical Sciences 2011;
liver sinusoidal endothelium impairs the
66:(1),3-8.
hepatic clearance of acetaminophen
in rats. The Journals of Gerontology
Le Couteur DG, Cogger VC, Dobbs B,
Series
A: Biological Sciences and
Fraser R. Fenestrations and lipoproteins.
Medical
Sciences 2011; 66:(4),400-8.
Cardiovascular Patholology 2011;
20:(3),191-3; author reply 3-4.
Le Couteur DG, McLachlan AJ, de Cabo
R. Aging, Drugs, and Drug Metabolism.
The Journals of Gerontology Series
A: Biological Sciences and Medical
Sciences [Epub ahead of print].
Le Couteur DG, McLachlan AJ, Quinn
RJ, Simpson SJ, de Cabo R. Aging
Biology and Novel Targets for Drug
Discovery. The Journals of Gerontology
Series A: Biological Sciences and
Medical Sciences [Epub ahead of print].
Le Couteur DG, Simpson SJ. Adaptive
senectitude: the prolongevity effects
of aging. The Journals of Gerontology
Series A: Biological Sciences and
Medical Sciences 2011; 66:(2),179-82.
Lusk MJ, Konecny P, Naing ZW, Garden
FL, Cumming RG, Rawlinson WD.
Mycoplasma genitalium is associated
with cervicitis and HIV infection in an
urban Australian STI clinic population.
Sexually Transmitted Infections 2011;
87:(2),107-9.
Hilmer SN, Tran K, Rubie P,
Wright J, Gnjidic D, Mitchell SJ,
Matthews S, Carroll PR. Gentamicin
pharmacokinetics in old age and frailty.
British Journal of Clinical Pharmacology McLachlan AJ, Bath S, Naganathan
2011; 71:(2), 224-31.
V, Hilmer SN, Le Couteur DG, Gibson
Kanjanarach T, Krass I, Cumming RG.
SJ, Blyth FM. Clinical pharmacology
Australian community pharmacists’
of analgesic medicines in older
practice in complementary medicines: a people: impact of frailty and cognitive
structural equation modelling approach. impairment. British Journal of Clinical
Patient Education and Counselling 2011; Pharmacology 2011; 71:(3),351-64.
83:(3),352-9.
McLachlan AJ, Pont LG. Drug
Labbe A, Garand C, Cogger VC,
Paquet ER, Desbiens M, Le Couteur
DG, Lebel M. Resveratrol improves
insulin resistance hyperglycemia
and hepatosteatosis but not
hypertriglyceridemia, inflammation, and
life span in a mouse model for Werner
syndrome. The Journals of Gerontology
Hilmer SN. Poloxamer 407 increases
the recovery of paracetamol in the
isolated perfused rat liver. Journal
of Pharmaceutical Sciences 2011;
100:(1),334-40.
Metabolism in Older People--A Key
Consideration in Achieving Optimal
Outcomes With Medicines. The
Journals of Gerontology Series A:
Biological Sciences and Medical
Sciences [Epub ahead of print].
Mitchell SJ, Huizer-Pajkos A, Cogger
VC, McLachlan AJ, Le Couteur DG,
Nabipour I, Cumming R, Handelsman
DJ, Litchfield M, Naganathan V,
Waite L, Creasey H, Janu M, Le
Couteur D, Sambrook PN, Seibel
MJ. Socioeconomic status and bone
health in community-dwelling older
men: the CHAMP Study. Osteoporosis
International 2011; 22:(5),1343-53.
Nabipour I, Sambrook PN, Blyth FM,
Janu MR, Waite LM, Naganathan
V, Handelsman DJ, Le Couteur DG,
Cumming RG, Seibel MJ. Serum uric
acid is associated with bone health in
older men: a cross-sectional populationbased study. Journal of Bone and
Mineral Research 2011; 26:(5),955-64.
Negin J, Cumming R, de Ramirez SS,
Abimbola S, Sachs SE. Risk factors for
non-communicable diseases among
older adults in rural Africa. Tropical
Medicine and International Health 2011;
16:(5),640-6.
Negin J, van Lettow M, Semba M,
Martiniuk A, Chan A, Cumming RG.
Anti-Retroviral Treatment Outcomes
among Older Adults in Zomba District,
Malawi. PLoS One 2011; 6:(10),e26546.
Newington JT, Pitts A, Chien A,
Arseneault R, Schubert D, Cumming RC.
Amyloid beta resistance in nerve cell
lines is mediated by the Warburg effect.
PLoS One 2011; 6:(4),e19191.
Nishtala PS, McLachlan AJ, Bell JS,
Chen TF. A retrospective study of drugrelated problems in Australian aged care
homes: medication reviews involving
pharmacists and general practitioners.
The Journal of Evaluation in Clinical
Practice 2011; 17:(1),97-103.
Perera V, Gross AS, Xu H, McLachlan
34
PUBLICATIONS
AJ. Pharmacokinetics of caffeine in
plasma and saliva, and the influence
of caffeine abstinence on CYP1A2
metrics. Journal of Pharmacy and
Pharmacology 2011; 63:(9),1161-8.
Phan VH, Tan C, Rittau A, Xu H,
McLachlan AJ, Clarke SJ. An update on
ethnic differences in drug metabolism
and toxicity from anti-cancer drugs.
Expert Opinion on Drug Metabolism
and Toxicology 2011; 7:(11),1395-410.
Sambrook PN, Cameron ID, Chen JS,
Cumming RG, Durvasula S, Herrmann
M, Kok C, Lord SR, Macara M, March
LM, Mason RS, Seibel MJ, Wilson N,
Simpson JM. Does increased sunlight
exposure work as a strategy to improve
vitamin D status in the elderly: a
cluster randomised controlled trial.
Osteoporosis International [Epub ahead
of print].
Sambrook PN, Cameron ID, Chen JS,
March LM, Simpson JM, Cumming RG,
Seibel MJ. Oral bisphosphonates are
associated with reduced mortality in
frail older people: a prospective fiveyear study. Osteoporosis International
2011; 22:(9),2551-6.
Sherrington C, Lord SR, Close JC,
Barraclough E, Taylor M, O’Rourke S,
Kurrle S, Tiedemann A, Cumming RG,
Herbert RD. A simple tool predicted
probability of falling after aged care
inpatient rehabilitation. Journal of
Clinical Epidemiology 2011; 64:(7),77986.
DJ, Le Couteur DG, Waite LM, Creasey
HM, Seibel MJ, Sambrook PN. Ethnicity
and falls in older men: low rate of falls
in Italian-born men in Australia. Age and
Ageing 2011; 40:(5),595-601.
Chan BY, Fuller ES, Russell A, Smith
SS, Smith MM, Jackson MT, Cake
MA, Read RA, Bateman JF, Sambrook
Stanaway FF, Kendig HL, Blyth FM,
PN, Little CB. Increased chondrocyte
Cumming RG, Naganathan V, Waite LM. sclerostin may protect against
Subjective social support in older male
cartilage degradation in osteoarthritis.
Italian-born immigrants in Australia.
Osteoarthritis Cartilage. 2011;19:874-85
Journal of Cross-Cultural Gerontology
Clarke EC. Spinal cord mechanical
2011; 26:(2),205-20.
properties, invited chapter in Neural
Stocker SL, Graham GG, McLachlan AJ, tissue biomechanics, in series: Studies
Williams KM, Day RO. Pharmacokinetic
in Mechanobiology, Tissue Engineering
and pharmacodynamic interaction
and Biomaterials, Springer-Verlag,
between allopurinol and probenecid
Berlin Heidelberg, Germany, 2011, 25-40.
in patients with gout. Journal of
Clarke EC, Cheng S, Green M, Sinkus
Rheumatology 2011; 38:(5),904-10.
R, Bilston LE. Using static preload
Travison TG, Nguyen AH, Naganathan
with magnetic resonance elastography
V, Stanaway FF, Blyth FM, Cumming
to estimate large strain viscoelastic
RG, Le Couteur DG, Sambrook
properties of bovine liver, Journal of
PN, Handelsman DJ. Changes in
Biomechanics, 2011, 44 (13): 2461-2465.
reproductive hormone concentrations
Herbert RD, Clarke J, Kwah LK,
predict the prevalence and progression Diong J, Martin J, Clarke EC, Bilston
of the frailty syndrome in older men:
LE, Gandevia SE. In vivo passive
the concord health and ageing in
mechanical behaviour of muscle
men project. Journal of Clinical
fascicles and tendons in human
Endocrinology and Metabolism 2011;
gastrocnemius muscle-tendon units,
96:(8),2464-74.
Journal of Physiology-London 2011;
Warren A, Benseler V, Cogger VC,
Bertolino P, Le Couteur DG. The impact
of poloxamer 407 on the ultrastructure
of the liver and evidence for clearance
by extensive endothelial and kupffer
cell endocytosis. Toxicologic Pathology
2011; 39:(2),390-7.
Warren A, Cogger VC, Fraser R, Deleve
Stafford L, Peterson GM, Bereznicki LR, LD, McCuskey RS, Le Couteur DG.
Jackson SL, van Tienen EC, Angley MT, The effects of old age on hepatic
Bajorek BV, McLachlan AJ, Mullan JR,
stellate cells. Current Gerontology and
Misan GM, Gaetani L. Clinical outcomes Geriatrics Research 2011; 439835.
of a collaborative, home-based
Wilson N, Gnjidic D, March L,
postdischarge warfarin management
Sambrook P, Hilmer SN. Use of PPIs
service. Annals of Pharmacotherapy
are not associated with mortality in
2011; 45:(3),325-34.
institutionalized older people. Archives
Stanaway FF, Blyth FM, Cumming
of Internal Medicine 2011; 171:(9),866;
RG, Naganathan V, Handelsman DJ,
author reply -7.
Waite LM, Sambrook PN, Creasey
Wilson NM, Hilmer SN, March LM,
HM, Seibel MJ, Le Couteur DG.
Cameron ID, Lord SR, Seibel MJ, Mason
Back pain in older male Italian-born
RS, Chen JS, Cumming RG, Sambrook
immigrants in Australia: the importance PN. Associations between drug
of socioeconomic factors. European
burden index and falls in older people
Journal of Pain 2011; 15:(1),70-6.
in residential aged care. Journal of
Stanaway FF, Cumming RG,
Naganathan V, Blyth FM, Handelsman
BONE AND JOINT RESEARCH
FOUNDATION
the American Geriatric Society 2011;
59:(5),875-80.
589(21): 5257-5267
ENDOCRINOLOGY AND DIABETES
RESEARCH FOUNDATION
Craig ME, Twigg SM, Donaghue KC,
Cheung NW, Cameron FJ, Conn J,
Jenkins AJ, Silink M, for the Australian
Type 1 Diabetes Guidelines Expert
Advisory Group. National evidencebased clinical care guidelines for type
1 diabetes in children, adolescents
and adults, Australian Government
Department of Health and Ageing,
Canberra 2011.
Hart S, Abraham S, Franklin RC, Twigg
SM, Russell J. Hypoglycaemia following
a mixed meal in eating disorder patients.
Postgraduate Medical Journal. 2011;
Jun;87(1028):405-9.
Jones GR, Barker G, Goodall I,
Schneider HG, Shephard MD, Twigg
SM. Change of HbA1c reporting to the
new SI units. Medical Journal of Aust.
2011;195(1):45-6.
Lo L, McLennan SV, F Williams P,
Bonner J, Chowdhury S, McCaughan
GW, Gorrell MD, Yue DK, Twigg SM.
Diabetes is a progression factor for
hepatic fibrosis in a high fat fed
mouse obesity model of non-alcoholic
steatohepatitis. Journal of Hepatology.
2011; Aug; 55(2):435-44.
liver transplant tolerance. Transplant
Immunology 2011; 24: 138-9.
Wang C, Cordoba S, Hu M, Bertolino
P, Bowen DG, Sharland AF, Allen RD,
Alexander SI, McCaughan GW, Bishop
Perera NJ, Molyneaux L, Constantino
GA. Spontaneous acceptance of
MI, McGill M, Yue DK, Twigg SM,
mouse kidney allografts is associated
Ross GP. Suboptimal performance of
with increased Foxp3 expression
blood glucose meters in an antenatal
and differences in the B and T cell
diabetes clinic. Diabetes Care, 2011; Feb compartments. Transplant Immunology
34(2):335-7.
2011; 24: 149-56.
Perera NJ, Stewart PM, Williams PF,
Chua EL, Yue DK, Twigg SM. The
danger of using inappropriate pointof-care glucose meters in patients on
icodextrin dialysis. Diabetic Medicine.
2011; Oct;28(10):1272-6.
Pertot T, Molyneaux L, Tan K, Ross GP,
Yue DK, Wong J. Can common clinical
parameters be used to identify patients
who will need insulin treatment in
gestational diabetes mellitus? Diabetes
Care. 2011; Oct;34(10):2214-6.
Twigg SM, Irvine S, Leask A, Perbal
B. Report on the 6th international
workshop of the CCN family of genes.
Journal of Cell Communication and
Signalling. 2011; Mar;5(1):1-3.
Wang X, McLennan SV, Twigg SM.
CCN-2 is up-regulated by and mediates
effects of matrix bound advanced
glycated end-products in human
renal mesangial cells. Journal of Cell
Communication and Signalling. 2011;
Aug;5(3):193-200.
MICROSEARCH FOUNDATION OF
AUSTRALIA
Bishop GA, Ierino, FL, Sharland AF, Hall,
BM, Alexander SI, Sandrin MS, Coates
PT, McCaughan GW. Approaching the
promise of operational tolerance in
clinical transplantation. Transplantation
2011; 91: 1065-74.
Bishop GA, Ierino, FL, Sharland AF, Hall,
BM, Alexander SI, Sandrin MS, Coates
PT, McCaughan GW. Operational
tolerance in organ transplantation
versus tissue engineering: into the
future. Transplantation 2011; 92: e39.
van Leest Y, Moroso V, Wang C, Tay
SS, Cunningham E, Ilie V, Bishop GA,
Kwekkeboom J. (letter) No evidence
for involvement of donor NK cells in
36
DONATIONS
Sydney Medical School Foundation and its Divisions are indebted to the many individuals and organisations that supported
our research programs through donations and bequests in 2011. Donors of $250 or more are listed below. In addition to
those listed a significant number of other contributions were received during the year.
SYDNEY MEDICAL SCHOOL FOUNDATION
BEQUESTS
In 2011 Sydney Medical School
Foundation received a new bequest,
or an additional distribution, from the
following estates:
Estate of the Late Helen
Maureen Shaw
Estate of the Late
Gertrude Angel-Lord
Estate of the Late Doreen
Isabelle C Barnes
Estate of the Late Henry
Lloyd Brown
Estate of the Late Jean
Wright
Estate of the Late Boris
Serge Omelchuck
Estate of the Late Janet
Helen Winn
Estate of the Late Norma
Dorothy Free
Estate of the Late Shirley
Beckett Weymouth
$2,100,000
$120,000
$97,159
$66,000
$50,000
$6,154
$5,000
$1,316
$1,000
DONATIONS $250 AND OVER
Maple-Brown Family
Charitable Foundation Ltd $5,000,000
Mr Daniel Petre AO
$2,000,000
Australian Diabetes
Council
$1,000,000
Mr Michael Crouch AO
$500,000
Anonymous
$202,000
Anonymous
$100,000
Mr W Bruce Kirkpatrick OAM
& Mrs Juliet Kirkpatrick
$100,000
Mr Kevin Troy
$100,000
Mrs Janet Wilson
$50,600
Mr Richard A Longes
$50,000
Mr Leo Tutt
$40,000
The Reginald Ward &
Adrian Cotter Foundation
$37,000
Balmain Rotary Club
$32,825
Bluesand Foundation
$25,000 Miss Alison Stephen
Sky Foundation
$25,000 Dr Doug Williams
Mrs Diana Hardy
$16,000 Anonymous
Dr Francis M Hooper
$15,000 Research Australia
Mr David Burns
$10,000 Dr Aaron Hung
Dr Edward Halliday
$10,000 Mr Mark Holmes
Mrs Patricia Ho
$10,000 Dr John Jefferis
Mrs Pamela Lumb
$10,000 Mrs Caroline Kollman
L&M Cowan Foundation
$7,440 Dr Helen Morrison
Professor Lyn Gilbert
$5,050 Dr Robert Wilson
Professor Tania Sorrell
$5,050 Dr Denise Fung
Anonymous
$5,000 Dr Bill Thoo
Mr Ian Dunlop
$5,000 Mr Dennis O’Brien
Dr Edward Griffin
$5,000 Dr Warick Benson
Ms Janet Lee
$5,000 Dr Helen Bashir
Mr Owen Chew Lee
$5,000 Mrs Sheila M Green
Dr Christine Lopackinski
$5,000 Anonymous
Mr Robert Maple-Brown AO
$5,000 Anonymous
Marich Foundation
$5,000 Dr Gregory Barnes
Dr Kenneth Neale
$5,000 Bloomfield Group Foundation
Meniere’s Australia Ltd
$4,814 Mrs Rosa Bova
Craig Mostyn and Company
Clinical Associate Professor
Pty Limited
$4,000 Katherine Brown
Professor William Gibson AM $4,000 Emeritus Professor John
Chalmers AC
Broinowski Foundation Pty
Limited
$3,000 Ms Maureen Chan
Dr Edward Morgan
$3,000 Dr Douglas Chester
Mr Robert Mostyn
$3,000 Mr Geoffery Clissold
Ms P Moss
$2,970 Ms Barbara Crouch
Robert J Lusby Pty Ltd
$2,800 EAC Charity Club
Dr Sheela Brahmbhatt
$2,222 Mr Hugh Dixson
Mr Roy Randall
$2,100 Dr Angela Evans
Mr Graham Barr
$2,000 Mr James Fairfax AC
Dr John Bishop
$2,000 Mr Peter Griffiths
Mr Donald Faithfull
$2,000 Mr Clive Hall
Mr Brian France
$2,000 Mr William Hayward
Dr David Green
$2,000 Dr Geoffery Jordan
Dr Chee Leong Hiew
$2,000 Dr Paul Lai
Mr Derek Lightfoot
$2,000 Mrs Wendy Miles
Ms Priscilla Roussel
$2,000 Dr William Muston
$2,000
$2,000
$1,932
$1,600
$1,545
$1,500
$1,500
$1,500
$1,450
$1,300
$1,200
$1,200
$1,116
$1,100
$1,050
$1,050
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
Dr Lawrence Nguyen
Dr Ban Ong
Dr Cheryl Quinton
Dr William Regan AM
Dr Robyn Smiles
Mr Michael Smithers
Dr Charles Toh
Professor James Wiley
Dr Victor Wilson
Dr Richard Wing
Dr Goh Wong
Dr Anna Ziegler
Dr Howard Peake OAM
Dr James Roche OAM
Mrs D Benson
Mr Ugo La Rocca
Dr Denise Sporr
Dr Alan Timbs &
Mrs Audrey Timbs
Dr William Nelson &
Dr Sarah Nelson
Ms Phyllis Alston
Dr Keith Burgess
Ms Dorothy Burgess
Mr and Mrs Peter Carey
Dr Jeanette Carter
Dr Barry Chapman
Mrs Ann Clark
Mrs Rosemary Clarke
Dr John Connors
Dr Bernard Cook
Dr Gregory Crossland
Mrs Gwen Dovey
Dr Barry Flynn
Mrs Phillipa France
Mrs Bunny Gardiner-Hill
Dr Martin Kennedy
Dr Alison Kesson
Mrs Anna-Lisa Klettenburg
Emeritus Professor Paul Korner
AO FAA FRCP
Dr Paddy Lightfoot OAM
Dr Marion Maxwell
Professor James May AC
Mrs Laurel Mccartney
Mrs Catherine Moxham
Dr Alan Nicholls AM
Nossal Family Trust
Dr Andres Paas
Dr Raymond Raper
Mr Malcolm Reid
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$1,000
$900
$800
$800
$700
$700
$700
$700
$650
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
$500
Mrs Colleen Reid
Dr Nancy Rickard
Dr Paul Schnitzler
Dr Alice Steele Smith
Dr Susan Stephens
Dr Cornelius van der Weyden
Dr Bruce Warren
Mr Robert White AO
Mrs Rosalind Wong
Dr Desmond Yip
Dr Titia Sprague
Dr Peter Crowe
Dr Christopher Porkony
Dr Peter Rogers
Dr Ben Balzer
Dr Hazel Evans
Mr Anthony Bookalil
Dr Stephen Barratt
Dr Timothy Finucan
Dr Bruce Gunner
Dr Ray Holdings
Mrs Rebecca Kirby
Dr Alan McLean
Mr Rupert Mok
Mrs Diana Newton
Mrs Helga Pettitt
Miss LM Ray
Dr Diana Semmonds
Mrs Pamela Wilhelm
Dr Kenneth Wilson
Ms Rosemary Blemings
Dr Denis Chow
Dr Roger Davidson
Dr David Dixon
Dr Sunthra Manickam
Dr Anthony McDonald
Dr Patrick Morrison
Dr Robert Munro
Dr Gordon Pettitt
Mrs M Prell
Dr Edward Sun
Dr Michael Peterson
Dr Margaret Sheridan
Dr Richard Bull
Dr John Blackman
Dr Susan Cherry
Dr James Chesworth
Dr Rodney Clark
Dr Frederick Clarke
Dr Michael Graham
Dr I A Grice
$500 Dr Henry Houston
$500 Mrs Nan Hunt
$500 Dr Frank Johnson
$500 Dr George Kalnins
$500 Dr James Kench
$500 Dr Karen Kirwan
$500 Dr Stanley McCarthy AO
$500 Dr Stephen McNamara
$500 Dr Glenys Miller
$500 Mr R Morrall
$480 Dr Alice Park
$450 Dr Joo Quah-Smith
$450 Mr Murray Roberts
$450 Brigadier Derek Sharp OBE
$400 Dr Martin R Stockler
$400 Dr Siah Tan
$400 Dr Diana Tolhurst
$400 Dr Jie Jin Wang
$400 Dr John Warneford
$400 Dr Timothy Wong
$400 Dr Kean Yeoh
$400 Mr Tom Philp
$400 Associate Professor Michael
$400 Veness
$400 Dr Jennifer Arnold
$400 Mrs Ruth Barry
$400 Mr Andrew Bova
$400 Dr Barry Bracken
$400 Mr Peter Brun
$400 Dr John Burgess
$350 Miss Deborah Burke
$350 Dr Venu Chalasani
$350 Dr Richard Crago
$350 Dr Helen Croaker
$350 Dr Catherine Faehrmann
$350 Dr Ian Fulcher
$350 Mrs Judith Gollan
$350 Dr Judith Hay-Rees
$350 Mr Robert Hiatt
$350 Associate Professor Henry
$350 Kilham
$333 Mrs Jill Kloster
$333 Dr Rosalind Lehane
$325 Dr Kim Leung
$320 Dr Francis Newman
$300 Dr Lorraine O’Brien
$300 Dr Roderick Plowman
$300 Mrs Ruth Rae
$300 Dr Susan Reid
$300 Dr Allan Rosenburg
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$300
$275
$275
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
$250
38
DONATIONS
Professor Richard Charles
Russell
Dr Nicholas Saltos
Dr Gary Scarf
Mr Barry Scotchbrook
Professor David Sillence
$250
$250
$250
$250
$250
Mr Graham Spencer
Mr John Slack
Dr Sandra Taylor
Dr Enn Tohver
Dr Sidney Tong
Dr Amelia Traino
$250
$250
$250
$250
$250
$250
Dr Selwyn Trenerry
Dr Furio Virant
Ms Kitty Watt
Dr Wendy Webb
Dr Douglas Welch
$250
$250
$250
$250
$250
Mr John Bowker
Mrs Irmajant Prajogo
Mr John Schofield
$500
$250
$250
Mrs Dorothy Heazlett
Mrs Enid Stone
Naval Association of Australia
Canterbury Bankstown Sub Sect
Dr John Austin
$300
$300
DIVISIONS
AGEING AND ALZHEIMER’S
RESEARCH FOUNDATION
Estate of the Late Margaret
$300
Brown Wright
$239,438
$250
Anonymous
$26,640 MICROSEARCH FOUNDATION OF
AUSTRALIA
Estate of the Late Arthur
SYDNEY BURNS FOUNDATION
Ronald Brown
$10,500 Estate of the Late William
John Charles Hill
$72,225 Ausgrid
$50,000
BONE AND JOINT RESEARCH
Estate of the Late Violet Falls $36,562 Andrew McNaughten
FOUNDATION
Foundation
$10,000
Estate of the Late Harold
Phillips
$28,140 Schrader Legal
Estate of the Late
$5,000
Margaret Liggins
$1,500,000 Mr George Andrews
$2,500 Mr Clement Skevington
$2,400
Woodend Pty Ltd
$30,000 NHST Pty Ltd
$2,000 Anonymous
$2,434
Dr Michael Hunter
$500 Mr Andrew Richardson
$2,000 Mr Kevin Cranfield
$1,500
Mrs Susan Holman
$400 Dr Agnes Sinclair
$2,000 Stewart Partners Pty Ltd
$1,500
Mrs Jean Parsons
$300 Mr John Townsend
$2,000 Mr David Barnsdall OAM
$1,000
Mrs Jill Hicks
$250 Mr Phillip Townsend
$2,000 Dr Samuel Cook
$1,000
Mr Petr Szorenyi
$250 Douglass Hanly Moir Pathology
Dr Gordon Clowes
$800
Pty Ltd
$1,000 Mr John Ironmonger
$800
DERMATOLOGY RESEARCH
MDA National Insurance
Mr
Chris
Corneil
$500
FOUNDATION
Company
$1,000 Mrs Catherine Moxham
$500
Mr Neil Hill
$10,000 Mr Don Stein AM
$1,000 Ms Tracy Steggall
$500
Mr Charles Dawson
$500 Mrs Beryl Woodgate
$1,000 Mr William Webster
$500
Mr James Robinson
$500 Mr John Cameron
$950 Mr James Winch
$500
Mrs T Robinson
$500 Expatriate Club
$900 Mrs Mary Rose Mcdonald
$250
Dr John Gaudin
$450 Mrs Norma Robertson
$900
Mr Emmanuel Kokas
$450 Mr Gilson Webb
$800
Mr Herman Doorn
$300 Mr Neil Anderson
$500
Ms Elizabeth Morris
$300 Mrs Valda Eastment
$500
Dr John Sippe
$250 Lions Club of Manly
$500
NSW Women’s Bowl for
ENDOCRINOLOGY AND DIABETES
Others Club
$500
RESEARCH FOUNDATION
Mr John Phillips OAM
$500
Karcraft Australia Pty Ltd
$50,000
Mrs Jean Redman
$500
Professor Dennis Yue AM
$40,000
Mr James Bell
$350
Entoure Cycle for Life
$31,550
Ms Erica Rasche
$350
The Federation of Thessalian
Mrs Lorna Simpson
$350
Associations
$10,000
Mr W Duffy
$300
Mrs Patricia Taperell
$1,000
Mrs Helen Goddard
$300
Premier Media Group Australia $834
SUPPORT SYDNEY MEDICAL
SCHOOL FOUNDATION
OUR MISSION
Sydney Medical School Foundation is dedicated to improving
the health of all Australians by investing in a program of
world-class research and learning in Sydney Medical School
at the University of Sydney.
DONATIONS
Our many accomplishments would not be possible without
the support of our friends and donors. If you would like to
support Sydney Medical School Foundation or one of our
Divisions please contact us at:
Sydney Medical School Foundation
Room 212
Edward Ford Building A27
The University of Sydney NSW 2006
T +61 2 9351 7315
F +61 2 9036 9182
E [email protected]
BEQUESTS
A bequest to Sydney Medical School Foundation is a
contribution to the health of future generations. Many of
our major research programs have been made possible by
bequests.
If you are considering a bequest to Sydney Medical School
Foundation, and would like to discuss this further in person,
Ms Wendy Marceau, our Senior Development Officer,
Planned Giving, is able to liaise with you or your solicitor.
For further information on how to make a bequest, or to
make an appointment with Wendy, please contact:
T +61 2 8627 8492
F +61 2 8627 8819
E [email protected]
Sydney Medical School Foundation is a foundation of the
University of Sydney. The University of Sydney is endorsed
as a deductible gift recipient under Subdivision 30-BA of the
Income Tax Assessment Act 1997.
To donate online visit our website at:
sydney.edu.au/medicine/foundation
Please accept my:
Money Order
Cheque
Credit Card
(Payable to Sydney Medical School Foundation, the University of Sydney)
Yes, I would like to support
Sydney Medical School Foundation
Credit card details:
Visa
Please accept my gift of: $
Title:
Mr
Ms
Mrs
Dr
Other
First name:
Diners Club
Cardholder’s name:
/
Signature:
Phone:
Address:
Email:
Suburb:
State:
American Express
Card No:
Expiry:
Last name:
MasterCard
Postcode:
Please send me information about how I can remember the University of
Sydney in my will for the purposes of the Sydney Medical School Foundation.
I confirm that I have included the University of Sydney in my will for the
purposes of Sydney Medical School Foundation.
Development Office, Level 6, Jane Foss Russell Building (G02)
The University of Sydney, NSW 2006 Australia
T +61 2 8627 8818
F +61 2 8627 8819
E [email protected]
sydney.edu.au/supportsydney
The information you provide on this form is collected by the University of Sydney to maintain contact and keep you up-to-date with
information about the University, its services, events and achievements. It may be passed on to groups affiliated with the University, such
as alumni organisations and foundations (local and overseas), SU Sport and residential colleges. Your name may be published in the annual
honour roll. If you wish to remain anonymous or do not wish to receive information, please contact Advancement Services via fax (F +61 2
8627 8819), or email (E [email protected]). The University abides by the “NSW Privacy and Personal Information Protection
Act”.
ABN 15 211 513 464
CRICOS 00026A
CFN 10369 0411
40
INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2011
Notes
31 December
2011
$
31 December
2010
$
44,967
15,000
INCOME
Grants
Donations, Bequests & Scholarships
2
Business and Investment Income
15,119,381
3,942,424
2,882,152
2,713,606
182,583
45,178
18,229,083
6,716,208
477,582
222,665
116,787
121,322
4,149,318
4,135,759
4,743,687
4,479,746
13,485,396
2,236,462
53,714,072
51,477,610
5,395,000
-
72,594,469
53,714,072
Internal & Other Income
Total Income
EXPENDITURE
Salaries
Other Expenses
Contributions to Research, Schools & Centres
Total Expenditure
SURPLUS
Accumulated Funds as at 1 January
Transfer from Reserves
TOTAL ACCUMULATED FUNDS
3
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2011
1.
Statement of Significant Accounting Policies:
( a ) These accounts have been prepared on a cash basis and amounts are stated at historical cost.
( b ) These accounts are the consolidated accounts of Sydney Medical School Foundation and its divisional foundations,
namely:
•
Ageing & Alzheimers Research Foundation
•
Bone and Joint Research Foundation
•
Dermatology Research Foundation
•
Endocrinology & Diabetes Research Foundation
•
Microsearch Foundation of Australia
•
Sydney Burns Foundation.
( c ) Income tax is not applicable to activities of the Foundation.
( d ) All fixed assets are expensed in the year of purchase with the exception of the interest in a property.
2.
Donations & Bequests: Donations & Bequests includes $5M received from Maple-Brown Family Charitable Foundation
Limited for Lifehouse at RPA. As per the terms of the Gift Deed, this donation needs to be transferred to the Lifehouse
at RPA in June 2012 for construction of a cancer research clinic.
3.
Reserves: Pursuant to the Reserves Policy of the University, reserves held in the account of R W Storr Cancer Bequest
(B3153) as of December 2010 were moved to accumulated funds in July 2011. As per the Reserves Policy, reserves can
not be held in the Bequests/Donation accounts.
BALANCE SHEET
AS AT 31 DECEMBER 2011
Notes
31 December
2011
$
31 December
2010
$
ASSETS
Current Assets
Petty Cash
Funds Participating in University Pool Interest
Total Current Assets
700
700
45,141,953
33,356,557
45,142,653
33,357,257
Non Current Assets
Interest in Medical Foundation Building
4
10,000,000
10,000,000
Investments
5
17,451,816
15,751,815
27,451,816
25,751,815
72,594,469
59,109,072
72,594,469
53,714,072
-
5,395,000
72,594,469
59,109,072
Total Non Current Assets
Total Assets
EQUITY
Accumulated Funds
Reserves
Total Equity
3
NOTES CONTINUED...
4.
Interest in the Medical Foundation Building: The Medical Foundation Building was held to meet service delivery
objectives rather than to earn rental income or for capital appreciation and was treated as Commercial Teaching &
Research Building. The amounts shown in these financial statements as of December 2011 reflect Sydney Medical
School Foundation’s 54% share of the initial cash purchase price.
5.
Investments: The University holds Growth Fund Investments at cost. The market values of these investments as at
31st December 2011 was $15,879,076( $15,381,573; 2010)
I certify that the Income Statement and Balance Sheet of the Foundation have been prepared in accordance with the
University’s accounting practices and procedures. These Foundation accounts form part of the University of Sydney’s
financial reports which have been audited by the Auditor-General, New South Wales.
Sukumar Narayanan
Acting Finance Director, Faculties of Health
March 28, 2012
Sydney Medical School Foundation
T +61 2 9351 7315
F +61 2 9036 9182
E [email protected]
sydney.edu.au/medicine/foundation
SYDNEY MEDICAL
SCHOOL
FOUNDATION
Produced by Sydney Medical School Foundation, the University of Sydney, March
2011. The University reserves the right to make alterations to any information
contained within this publication without notice.
ABN 15 211 513 464
CRICOS 00026A